{"idB": "3116_12_item1_p11_s1", "idA": "3116_11_item1_p0_s0", "sentA": "We manufacture and market a full line of diagnostic and therapeutic ophthalmic pharmaceuticals as well as niche hospital drugs and injectable pharmaceuticals.", "sentB": "This plant currently manufactures liquid general pharmaceutical injectables, and injectable and oral cephalosporins, sterile injectable carbapenem and hormone products and is being expanded to allow for production of oncology products as well.", "type": 1, "words": ["<tag1>", "We", "manufacture", "and", "market", "a", "full", "line", "of", "diagnostic", "and", "therapeutic", "ophthalmic", "pharmaceuticals", "as", "well", "as", "niche", "hospital", "drugs", "and", "injectable", "pharmaceuticals.", "<tag2>", "This", "plant", "currently", "manufactures", "liquid", "general", "pharmaceutical", "injectables,", "and", "injectable", "and", "oral", "cephalosporins,", "sterile", "injectable", "carbapenem", "and", "hormone", "products", "and", "is", "being", "expanded", "to", "allow", "for", "production", "of", "oncology", "products", "as", "well.", "<tag3>"], "wordsA": ["We", "manufacture", "and", "market", "a", "full", "line", "of", "diagnostic", "and", "therapeutic", "ophthalmic", "pharmaceuticals", "as", "well", "as", "niche", "hospital", "drugs", "and", "injectable", "pharmaceuticals."], "wordsB": ["This", "plant", "currently", "manufactures", "liquid", "general", "pharmaceutical", "injectables,", "and", "injectable", "and", "oral", "cephalosporins,", "sterile", "injectable", "carbapenem", "and", "hormone", "products", "and", "is", "being", "expanded", "to", "allow", "for", "production", "of", "oncology", "products", "as", "well."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_12_item1_p11_s0", "idA": "3116_11_item1_p13_s0", "sentA": "As of December 31, 2010, we had 22 full-time employees directly involved in product research and development activities.", "sentB": "As of February 28, 2012, we own and operate a foreign manufacturing complex in Paonta Sahib, Himachal Pradesh, India.", "type": 1, "words": ["<tag1>", "As", "of", "December", "31,", "2010,", "we", "had", "22", "full-time", "employees", "directly", "involved", "in", "product", "research", "and", "development", "activities.", "<tag2>", "As", "of", "February", "28,", "2012,", "we", "own", "and", "operate", "a", "foreign", "manufacturing", "complex", "in", "Paonta", "Sahib,", "Himachal", "Pradesh,", "India.", "<tag3>"], "wordsA": ["As", "of", "December", "31,", "2010,", "we", "had", "22", "full-time", "employees", "directly", "involved", "in", "product", "research", "and", "development", "activities."], "wordsB": ["As", "of", "February", "28,", "2012,", "we", "own", "and", "operate", "a", "foreign", "manufacturing", "complex", "in", "Paonta", "Sahib,", "Himachal", "Pradesh,", "India."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_12_item1_p1_s3", "idA": "3116_11_item1_p13_s0", "sentA": "As of December 31, 2010, we had 22 full-time employees directly involved in product research and development activities.", "sentB": "As of February 28, 2012, we also own and operate a manufacturing complex in Paonta Sahib, Himachal Pradesh, India through our wholly-owned subsidiary, Akorn India Private Limited.", "type": 1, "words": ["<tag1>", "As", "of", "December", "31,", "2010,", "we", "had", "22", "full-time", "employees", "directly", "involved", "in", "product", "research", "and", "development", "activities.", "<tag2>", "As", "of", "February", "28,", "2012,", "we", "also", "own", "and", "operate", "a", "manufacturing", "complex", "in", "Paonta", "Sahib,", "Himachal", "Pradesh,", "India", "through", "our", "wholly-owned", "subsidiary,", "Akorn", "India", "Private", "Limited.", "<tag3>"], "wordsA": ["As", "of", "December", "31,", "2010,", "we", "had", "22", "full-time", "employees", "directly", "involved", "in", "product", "research", "and", "development", "activities."], "wordsB": ["As", "of", "February", "28,", "2012,", "we", "also", "own", "and", "operate", "a", "manufacturing", "complex", "in", "Paonta", "Sahib,", "Himachal", "Pradesh,", "India", "through", "our", "wholly-owned", "subsidiary,", "Akorn", "India", "Private", "Limited."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_12_item1_p19_s1", "idA": "3116_11_item1_p17_s1", "sentA": "We have strategically focused our business development efforts on products that complement our existing product lines and are expected to have few competitors.", "sentB": "We may seek to acquire ANDAs and NDAs from other pharma companies, or pursue acquisition of independent businesses that we believe complement our existing business and provide us opportunities for growth.", "type": 1, "words": ["<tag1>", "We", "have", "strategically", "focused", "our", "business", "development", "efforts", "on", "products", "that", "complement", "our", "existing", "product", "lines", "and", "are", "expected", "to", "have", "few", "competitors.", "<tag2>", "We", "may", "seek", "to", "acquire", "ANDAs", "and", "NDAs", "from", "other", "pharma", "companies,", "or", "pursue", "acquisition", "of", "independent", "businesses", "that", "we", "believe", "complement", "our", "existing", "business", "and", "provide", "us", "opportunities", "for", "growth.", "<tag3>"], "wordsA": ["We", "have", "strategically", "focused", "our", "business", "development", "efforts", "on", "products", "that", "complement", "our", "existing", "product", "lines", "and", "are", "expected", "to", "have", "few", "competitors."], "wordsB": ["We", "may", "seek", "to", "acquire", "ANDAs", "and", "NDAs", "from", "other", "pharma", "companies,", "or", "pursue", "acquisition", "of", "independent", "businesses", "that", "we", "believe", "complement", "our", "existing", "business", "and", "provide", "us", "opportunities", "for", "growth."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_12_item1_p25_s1", "idA": "3116_11_item1_p18_s0", "sentA": "In 2004, as part of our business development efforts, we entered into a 50/50 strategic partnership with Strides Arcolab Limited ( Strides ) in a new company named Akorn-Strides LLC (the Joint Venture Company ) for the development and marketing of a number of injectable ANDA products for the U.S. hospital and alternate site markets.", "sentB": "The Company s plan is for this manufacturing plant to obtain FDA and other international certification so that it can manufacture product for export to the U.S. and other regulated markets.", "type": 1, "words": ["<tag1>", "In", "2004,", "as", "part", "of", "our", "business", "development", "efforts,", "we", "entered", "into", "a", "50/50", "strategic", "partnership", "with", "Strides", "Arcolab", "Limited", "(", "Strides", ")", "in", "a", "new", "company", "named", "Akorn-Strides", "LLC", "(the", "Joint", "Venture", "Company", ")", "for", "the", "development", "and", "marketing", "of", "a", "number", "of", "injectable", "ANDA", "products", "for", "the", "U.S.", "hospital", "and", "alternate", "site", "markets.", "<tag2>", "The", "Company", "s", "plan", "is", "for", "this", "manufacturing", "plant", "to", "obtain", "FDA", "and", "other", "international", "certification", "so", "that", "it", "can", "manufacture", "product", "for", "export", "to", "the", "U.S.", "and", "other", "regulated", "markets.", "<tag3>"], "wordsA": ["In", "2004,", "as", "part", "of", "our", "business", "development", "efforts,", "we", "entered", "into", "a", "50/50", "strategic", "partnership", "with", "Strides", "Arcolab", "Limited", "(", "Strides", ")", "in", "a", "new", "company", "named", "Akorn-Strides", "LLC", "(the", "Joint", "Venture", "Company", ")", "for", "the", "development", "and", "marketing", "of", "a", "number", "of", "injectable", "ANDA", "products", "for", "the", "U.S.", "hospital", "and", "alternate", "site", "markets."], "wordsB": ["The", "Company", "s", "plan", "is", "for", "this", "manufacturing", "plant", "to", "obtain", "FDA", "and", "other", "international", "certification", "so", "that", "it", "can", "manufacture", "product", "for", "export", "to", "the", "U.S.", "and", "other", "regulated", "markets."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_12_item1_p24_s3", "idA": "3116_11_item1_p1_s2", "sentA": "We operate pharmaceutical manufacturing facilities in Decatur, Illinois and Somerset, New Jersey.", "sentB": "The primary assets acquired were Kilitch s pharmaceutical manufacturing complex in Paonta Sahib, Himachal Pradesh, India and its ongoing book of business.", "type": 1, "words": ["<tag1>", "We", "operate", "pharmaceutical", "manufacturing", "facilities", "in", "Decatur,", "Illinois", "and", "Somerset,", "New", "Jersey.", "<tag2>", "The", "primary", "assets", "acquired", "were", "Kilitch", "s", "pharmaceutical", "manufacturing", "complex", "in", "Paonta", "Sahib,", "Himachal", "Pradesh,", "India", "and", "its", "ongoing", "book", "of", "business.", "<tag3>"], "wordsA": ["We", "operate", "pharmaceutical", "manufacturing", "facilities", "in", "Decatur,", "Illinois", "and", "Somerset,", "New", "Jersey."], "wordsB": ["The", "primary", "assets", "acquired", "were", "Kilitch", "s", "pharmaceutical", "manufacturing", "complex", "in", "Paonta", "Sahib,", "Himachal", "Pradesh,", "India", "and", "its", "ongoing", "book", "of", "business."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_12_item1_p23_s0", "idA": "3116_11_item1_p1_s3", "sentA": "The Decatur, Illinois facilities operate as part of Akorn, Inc., while the Somerset, New Jersey facility operates as Akorn (New Jersey), Inc., a wholly-owned subsidiary incorporated in Illinois.", "sentB": "The acquired portfolio consists of Nembutal , a Schedule II controlled drug, Diuril and Cogentin .", "type": 1, "words": ["<tag1>", "The", "Decatur,", "Illinois", "facilities", "operate", "as", "part", "of", "Akorn,", "Inc.,", "while", "the", "Somerset,", "New", "Jersey", "facility", "operates", "as", "Akorn", "(New", "Jersey),", "Inc.,", "a", "wholly-owned", "subsidiary", "incorporated", "in", "Illinois.", "<tag2>", "The", "acquired", "portfolio", "consists", "of", "Nembutal", ",", "a", "Schedule", "II", "controlled", "drug,", "Diuril", "and", "Cogentin", ".", "<tag3>"], "wordsA": ["The", "Decatur,", "Illinois", "facilities", "operate", "as", "part", "of", "Akorn,", "Inc.,", "while", "the", "Somerset,", "New", "Jersey", "facility", "operates", "as", "Akorn", "(New", "Jersey),", "Inc.,", "a", "wholly-owned", "subsidiary", "incorporated", "in", "Illinois."], "wordsB": ["The", "acquired", "portfolio", "consists", "of", "Nembutal", ",", "a", "Schedule", "II", "controlled", "drug,", "Diuril", "and", "Cogentin", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_12_item1_p19_s2", "idA": "3116_11_item1_p23_s3", "sentA": "To date we have received approval for three ANDAs, none of which has yet been launched due to aggressive market competition and price erosion.", "sentB": "During 2011 and early 2012, we completed three significant acquisitions.", "type": 1, "words": ["<tag1>", "To", "date", "we", "have", "received", "approval", "for", "three", "ANDAs,", "none", "of", "which", "has", "yet", "been", "launched", "due", "to", "aggressive", "market", "competition", "and", "price", "erosion.", "<tag2>", "During", "2011", "and", "early", "2012,", "we", "completed", "three", "significant", "acquisitions.", "<tag3>"], "wordsA": ["To", "date", "we", "have", "received", "approval", "for", "three", "ANDAs,", "none", "of", "which", "has", "yet", "been", "launched", "due", "to", "aggressive", "market", "competition", "and", "price", "erosion."], "wordsB": ["During", "2011", "and", "early", "2012,", "we", "completed", "three", "significant", "acquisitions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_12_item1_p24_s2", "idA": "3116_11_item1_p29_s0", "sentA": "We were unable to make a payment of approximately $3,375,000 for Td vaccine products that was due to MBL by February 27, 2009 under our MBL Distribution Agreement.", "sentB": "We paid $59.9 million in cash at closing, which includes $1.8 million in transaction-related taxes and duties, and may owe additional consideration of approximately $4.0 million.", "type": 1, "words": ["<tag1>", "We", "were", "unable", "to", "make", "a", "payment", "of", "approximately", "$3,375,000", "for", "Td", "vaccine", "products", "that", "was", "due", "to", "MBL", "by", "February", "27,", "2009", "under", "our", "MBL", "Distribution", "Agreement.", "<tag2>", "We", "paid", "$59.9", "million", "in", "cash", "at", "closing,", "which", "includes", "$1.8", "million", "in", "transaction-related", "taxes", "and", "duties,", "and", "may", "owe", "additional", "consideration", "of", "approximately", "$4.0", "million.", "<tag3>"], "wordsA": ["We", "were", "unable", "to", "make", "a", "payment", "of", "approximately", "$3,375,000", "for", "Td", "vaccine", "products", "that", "was", "due", "to", "MBL", "by", "February", "27,", "2009", "under", "our", "MBL", "Distribution", "Agreement."], "wordsB": ["We", "paid", "$59.9", "million", "in", "cash", "at", "closing,", "which", "includes", "$1.8", "million", "in", "transaction-related", "taxes", "and", "duties,", "and", "may", "owe", "additional", "consideration", "of", "approximately", "$4.0", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_12_item1_p34_s3", "idA": "3116_11_item1_p30_s4", "sentA": "Upon the termination of this agreement, we exited the biologics vaccines segment.", "sentB": "We are committed to maintaining and defending the trade names of AVR s products, as they are important in supporting the success and growth of this business.", "type": 1, "words": ["<tag1>", "Upon", "the", "termination", "of", "this", "agreement,", "we", "exited", "the", "biologics", "vaccines", "segment.", "<tag2>", "We", "are", "committed", "to", "maintaining", "and", "defending", "the", "trade", "names", "of", "AVR", "s", "products,", "as", "they", "are", "important", "in", "supporting", "the", "success", "and", "growth", "of", "this", "business.", "<tag3>"], "wordsA": ["Upon", "the", "termination", "of", "this", "agreement,", "we", "exited", "the", "biologics", "vaccines", "segment."], "wordsB": ["We", "are", "committed", "to", "maintaining", "and", "defending", "the", "trade", "names", "of", "AVR", "s", "products,", "as", "they", "are", "important", "in", "supporting", "the", "success", "and", "growth", "of", "this", "business."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_12_item1_p23_s2", "idA": "3116_11_item1_p31_s0", "sentA": "We consider the protection of discoveries in connection with our development activities important to our business.", "sentB": "This acquisition provided us with three branded, hospital injectables to add to our portfolio.", "type": 1, "words": ["<tag1>", "We", "consider", "the", "protection", "of", "discoveries", "in", "connection", "with", "our", "development", "activities", "important", "to", "our", "business.", "<tag2>", "This", "acquisition", "provided", "us", "with", "three", "branded,", "hospital", "injectables", "to", "add", "to", "our", "portfolio.", "<tag3>"], "wordsA": ["We", "consider", "the", "protection", "of", "discoveries", "in", "connection", "with", "our", "development", "activities", "important", "to", "our", "business."], "wordsB": ["This", "acquisition", "provided", "us", "with", "three", "branded,", "hospital", "injectables", "to", "add", "to", "our", "portfolio."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_12_item1_p20_s0", "idA": "3116_11_item1_p39_s0", "sentA": "Competitors in our contract services segment include Baxter International, Inc., Hospira, Inc., Ben Venue Laboratories, Inc. and Patheon, Inc.", "sentB": "On May 3, 2011, we acquired AVR Business Trust and its subsidiaries, Advanced Vision Research, Inc. and Advanced Vision Pharmaceuticals, LLC (collectively, \"AVR\") for $26.0 million in cash.", "type": 1, "words": ["<tag1>", "Competitors", "in", "our", "contract", "services", "segment", "include", "Baxter", "International,", "Inc.,", "Hospira,", "Inc.,", "Ben", "Venue", "Laboratories,", "Inc.", "and", "Patheon,", "Inc.", "<tag2>", "On", "May", "3,", "2011,", "we", "acquired", "AVR", "Business", "Trust", "and", "its", "subsidiaries,", "Advanced", "Vision", "Research,", "Inc.", "and", "Advanced", "Vision", "Pharmaceuticals,", "LLC", "(collectively,", "\"AVR\")", "for", "$26.0", "million", "in", "cash.", "<tag3>"], "wordsA": ["Competitors", "in", "our", "contract", "services", "segment", "include", "Baxter", "International,", "Inc.,", "Hospira,", "Inc.,", "Ben", "Venue", "Laboratories,", "Inc.", "and", "Patheon,", "Inc."], "wordsB": ["On", "May", "3,", "2011,", "we", "acquired", "AVR", "Business", "Trust", "and", "its", "subsidiaries,", "Advanced", "Vision", "Research,", "Inc.", "and", "Advanced", "Vision", "Pharmaceuticals,", "LLC", "(collectively,", "\"AVR\")", "for", "$26.0", "million", "in", "cash."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_12_item1_p25_s0", "idA": "3116_11_item1_p43_s0", "sentA": "We require a supply of quality raw materials and components to manufacture and package pharmaceutical products for ourselves and for third parties with which we have contracted.", "sentB": "The Paonta Sahib plant currently manufactures pharmaceutical products primarily for contract customers in India and for export to unregulated markets.", "type": 1, "words": ["<tag1>", "We", "require", "a", "supply", "of", "quality", "raw", "materials", "and", "components", "to", "manufacture", "and", "package", "pharmaceutical", "products", "for", "ourselves", "and", "for", "third", "parties", "with", "which", "we", "have", "contracted.", "<tag2>", "The", "Paonta", "Sahib", "plant", "currently", "manufactures", "pharmaceutical", "products", "primarily", "for", "contract", "customers", "in", "India", "and", "for", "export", "to", "unregulated", "markets.", "<tag3>"], "wordsA": ["We", "require", "a", "supply", "of", "quality", "raw", "materials", "and", "components", "to", "manufacture", "and", "package", "pharmaceutical", "products", "for", "ourselves", "and", "for", "third", "parties", "with", "which", "we", "have", "contracted."], "wordsB": ["The", "Paonta", "Sahib", "plant", "currently", "manufactures", "pharmaceutical", "products", "primarily", "for", "contract", "customers", "in", "India", "and", "for", "export", "to", "unregulated", "markets."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_12_item1_p24_s0", "idA": "3116_11_item1_p44_s0", "sentA": "In 2010, 2009 and 2008, a high percentage of our sales were to the three large wholesale drug distributors noted below.", "sentB": "On February 28, 2012, subsequent to the end of our 2011 fiscal year, we closed on our acquisition of selected assets of Kilitch Drugs (India) Limited ( Kilitch ).", "type": 1, "words": ["<tag1>", "In", "2010,", "2009", "and", "2008,", "a", "high", "percentage", "of", "our", "sales", "were", "to", "the", "three", "large", "wholesale", "drug", "distributors", "noted", "below.", "<tag2>", "On", "February", "28,", "2012,", "subsequent", "to", "the", "end", "of", "our", "2011", "fiscal", "year,", "we", "closed", "on", "our", "acquisition", "of", "selected", "assets", "of", "Kilitch", "Drugs", "(India)", "Limited", "(", "Kilitch", ").", "<tag3>"], "wordsA": ["In", "2010,", "2009", "and", "2008,", "a", "high", "percentage", "of", "our", "sales", "were", "to", "the", "three", "large", "wholesale", "drug", "distributors", "noted", "below."], "wordsB": ["On", "February", "28,", "2012,", "subsequent", "to", "the", "end", "of", "our", "2011", "fiscal", "year,", "we", "closed", "on", "our", "acquisition", "of", "selected", "assets", "of", "Kilitch", "Drugs", "(India)", "Limited", "(", "Kilitch", ")."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_12_item1_p34_s2", "idA": "3116_11_item1_p49_s0", "sentA": "AmerisourceBergen, Cardinal and McKesson are key distributors of our products, as well as a broad range of health care products for many other companies.", "sentB": "One of our acquired companies, AVR, maintains a line of OTC eye care products sold under trade names such as TheraTears and SteriLid , among others.", "type": 1, "words": ["<tag1>", "AmerisourceBergen,", "Cardinal", "and", "McKesson", "are", "key", "distributors", "of", "our", "products,", "as", "well", "as", "a", "broad", "range", "of", "health", "care", "products", "for", "many", "other", "companies.", "<tag2>", "One", "of", "our", "acquired", "companies,", "AVR,", "maintains", "a", "line", "of", "OTC", "eye", "care", "products", "sold", "under", "trade", "names", "such", "as", "TheraTears", "and", "SteriLid", ",", "among", "others.", "<tag3>"], "wordsA": ["AmerisourceBergen,", "Cardinal", "and", "McKesson", "are", "key", "distributors", "of", "our", "products,", "as", "well", "as", "a", "broad", "range", "of", "health", "care", "products", "for", "many", "other", "companies."], "wordsB": ["One", "of", "our", "acquired", "companies,", "AVR,", "maintains", "a", "line", "of", "OTC", "eye", "care", "products", "sold", "under", "trade", "names", "such", "as", "TheraTears", "and", "SteriLid", ",", "among", "others."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_12_item1_p24_s1", "idA": "3116_11_item1_p50_s1", "sentA": "We anticipate filling all current open backorders during 2011.", "sentB": "The acquisition was pursuant to a Business Transfer Agreement ( BTA ) between our subsidiary, Akorn India Private Limited, and Kilitch signed on October 6, 2011.", "type": 1, "words": ["<tag1>", "We", "anticipate", "filling", "all", "current", "open", "backorders", "during", "2011.", "<tag2>", "The", "acquisition", "was", "pursuant", "to", "a", "Business", "Transfer", "Agreement", "(", "BTA", ")", "between", "our", "subsidiary,", "Akorn", "India", "Private", "Limited,", "and", "Kilitch", "signed", "on", "October", "6,", "2011.", "<tag3>"], "wordsA": ["We", "anticipate", "filling", "all", "current", "open", "backorders", "during", "2011."], "wordsB": ["The", "acquisition", "was", "pursuant", "to", "a", "Business", "Transfer", "Agreement", "(", "BTA", ")", "between", "our", "subsidiary,", "Akorn", "India", "Private", "Limited,", "and", "Kilitch", "signed", "on", "October", "6,", "2011."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_12_item1_p30_s3", "idA": "3116_11_item1_p50_s1", "sentA": "We anticipate filling all current open backorders during 2011.", "sentB": "Subsequent agreement between the parties allowed for the continued sale of one product into June 2011.", "type": 1, "words": ["<tag1>", "We", "anticipate", "filling", "all", "current", "open", "backorders", "during", "2011.", "<tag2>", "Subsequent", "agreement", "between", "the", "parties", "allowed", "for", "the", "continued", "sale", "of", "one", "product", "into", "June", "2011.", "<tag3>"], "wordsA": ["We", "anticipate", "filling", "all", "current", "open", "backorders", "during", "2011."], "wordsB": ["Subsequent", "agreement", "between", "the", "parties", "allowed", "for", "the", "continued", "sale", "of", "one", "product", "into", "June", "2011."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_12_item1_p58_s1", "idA": "3116_11_item1_p53_s0", "sentA": "The time required by the FDA to review and approve NDAs and ANDAs is variable and, to a large extent, beyond our control.", "sentB": "The increase in 2011 over the prior two years was due to a large order for one injectable Akorn product, and international sales of TheraTears products following our acquisition of AVR in early May 2011.", "type": 1, "words": ["<tag1>", "The", "time", "required", "by", "the", "FDA", "to", "review", "and", "approve", "NDAs", "and", "ANDAs", "is", "variable", "and,", "to", "a", "large", "extent,", "beyond", "our", "control.", "<tag2>", "The", "increase", "in", "2011", "over", "the", "prior", "two", "years", "was", "due", "to", "a", "large", "order", "for", "one", "injectable", "Akorn", "product,", "and", "international", "sales", "of", "TheraTears", "products", "following", "our", "acquisition", "of", "AVR", "in", "early", "May", "2011.", "<tag3>"], "wordsA": ["The", "time", "required", "by", "the", "FDA", "to", "review", "and", "approve", "NDAs", "and", "ANDAs", "is", "variable", "and,", "to", "a", "large", "extent,", "beyond", "our", "control."], "wordsB": ["The", "increase", "in", "2011", "over", "the", "prior", "two", "years", "was", "due", "to", "a", "large", "order", "for", "one", "injectable", "Akorn", "product,", "and", "international", "sales", "of", "TheraTears", "products", "following", "our", "acquisition", "of", "AVR", "in", "early", "May", "2011."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_12_item1_p55_s2", "idA": "3116_11_item1_p54_s3", "sentA": "We responded to the Warning Letter in April 2007 providing clarifying information and describing corrective actions planned and/or completed After subsequent FDA inspection of our Decatur facility in July/August 2007 and related communications between us and the FDA, we were notified by the FDA in December 2007 that all cGMP issues had been satisfactorily resolved, resulting in removal of the Warning Letter's potential restrictions on new product approvals, approval of the lyophilization and filling operations of the Decatur facility and approval of the site transfer for manufacture of IC Green to the Decatur facility.", "sentB": "This recall was initiated when we were notified by the manufacturer of a syringe contained within the kit that the syringe was being recalled.", "type": 1, "words": ["<tag1>", "We", "responded", "to", "the", "Warning", "Letter", "in", "April", "2007", "providing", "clarifying", "information", "and", "describing", "corrective", "actions", "planned", "and/or", "completed", "After", "subsequent", "FDA", "inspection", "of", "our", "Decatur", "facility", "in", "July/August", "2007", "and", "related", "communications", "between", "us", "and", "the", "FDA,", "we", "were", "notified", "by", "the", "FDA", "in", "December", "2007", "that", "all", "cGMP", "issues", "had", "been", "satisfactorily", "resolved,", "resulting", "in", "removal", "of", "the", "Warning", "Letter's", "potential", "restrictions", "on", "new", "product", "approvals,", "approval", "of", "the", "lyophilization", "and", "filling", "operations", "of", "the", "Decatur", "facility", "and", "approval", "of", "the", "site", "transfer", "for", "manufacture", "of", "IC", "Green", "to", "the", "Decatur", "facility.", "<tag2>", "This", "recall", "was", "initiated", "when", "we", "were", "notified", "by", "the", "manufacturer", "of", "a", "syringe", "contained", "within", "the", "kit", "that", "the", "syringe", "was", "being", "recalled.", "<tag3>"], "wordsA": ["We", "responded", "to", "the", "Warning", "Letter", "in", "April", "2007", "providing", "clarifying", "information", "and", "describing", "corrective", "actions", "planned", "and/or", "completed", "After", "subsequent", "FDA", "inspection", "of", "our", "Decatur", "facility", "in", "July/August", "2007", "and", "related", "communications", "between", "us", "and", "the", "FDA,", "we", "were", "notified", "by", "the", "FDA", "in", "December", "2007", "that", "all", "cGMP", "issues", "had", "been", "satisfactorily", "resolved,", "resulting", "in", "removal", "of", "the", "Warning", "Letter's", "potential", "restrictions", "on", "new", "product", "approvals,", "approval", "of", "the", "lyophilization", "and", "filling", "operations", "of", "the", "Decatur", "facility", "and", "approval", "of", "the", "site", "transfer", "for", "manufacture", "of", "IC", "Green", "to", "the", "Decatur", "facility."], "wordsB": ["This", "recall", "was", "initiated", "when", "we", "were", "notified", "by", "the", "manufacturer", "of", "a", "syringe", "contained", "within", "the", "kit", "that", "the", "syringe", "was", "being", "recalled."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_12_item1_p24_s4", "idA": "3116_11_item1_p57_s0", "sentA": "We also manufacture and distribute several controlled-drug substances, the distribution and handling of which are regulated by the DEA.", "sentB": "Also acquired pursuant to the BTA were selected assets of NBZ Pharma Limited, a company affiliated with Kilitch, from which the Company acquired the rights to manufacture and distribute certain pharmaceuticals products.", "type": 1, "words": ["<tag1>", "We", "also", "manufacture", "and", "distribute", "several", "controlled-drug", "substances,", "the", "distribution", "and", "handling", "of", "which", "are", "regulated", "by", "the", "DEA.", "<tag2>", "Also", "acquired", "pursuant", "to", "the", "BTA", "were", "selected", "assets", "of", "NBZ", "Pharma", "Limited,", "a", "company", "affiliated", "with", "Kilitch,", "from", "which", "the", "Company", "acquired", "the", "rights", "to", "manufacture", "and", "distribute", "certain", "pharmaceuticals", "products.", "<tag3>"], "wordsA": ["We", "also", "manufacture", "and", "distribute", "several", "controlled-drug", "substances,", "the", "distribution", "and", "handling", "of", "which", "are", "regulated", "by", "the", "DEA."], "wordsB": ["Also", "acquired", "pursuant", "to", "the", "BTA", "were", "selected", "assets", "of", "NBZ", "Pharma", "Limited,", "a", "company", "affiliated", "with", "Kilitch,", "from", "which", "the", "Company", "acquired", "the", "rights", "to", "manufacture", "and", "distribute", "certain", "pharmaceuticals", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_12_item1_p21_s0", "idA": "3116_11_item1_p5_s0", "sentA": "We market a line of niche hospital drug and injectable pharmaceutical products, including antidotes, anti-infectives, controlled substances for pain management and anesthesia, and other selected pharmaceutical products.", "sentB": "AVR is a developer and marketer of a line of OTC eye care products marketed primarily under the TheraTears brand name.", "type": 1, "words": ["<tag1>", "We", "market", "a", "line", "of", "niche", "hospital", "drug", "and", "injectable", "pharmaceutical", "products,", "including", "antidotes,", "anti-infectives,", "controlled", "substances", "for", "pain", "management", "and", "anesthesia,", "and", "other", "selected", "pharmaceutical", "products.", "<tag2>", "AVR", "is", "a", "developer", "and", "marketer", "of", "a", "line", "of", "OTC", "eye", "care", "products", "marketed", "primarily", "under", "the", "TheraTears", "brand", "name.", "<tag3>"], "wordsA": ["We", "market", "a", "line", "of", "niche", "hospital", "drug", "and", "injectable", "pharmaceutical", "products,", "including", "antidotes,", "anti-infectives,", "controlled", "substances", "for", "pain", "management", "and", "anesthesia,", "and", "other", "selected", "pharmaceutical", "products."], "wordsB": ["AVR", "is", "a", "developer", "and", "marketer", "of", "a", "line", "of", "OTC", "eye", "care", "products", "marketed", "primarily", "under", "the", "TheraTears", "brand", "name."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_12_item1_p11_s2", "idA": "3116_11_item1_p60_s0", "sentA": "Seasonality and other Cyclical Sales Fluctuations .", "sentB": "The Paonta Sahib plant currently manufactures product for Indian contract customers and for export to African, Asian and other unregulated markets.", "type": 1, "words": ["<tag1>", "Seasonality", "and", "other", "Cyclical", "Sales", "Fluctuations", ".", "<tag2>", "The", "Paonta", "Sahib", "plant", "currently", "manufactures", "product", "for", "Indian", "contract", "customers", "and", "for", "export", "to", "African,", "Asian", "and", "other", "unregulated", "markets.", "<tag3>"], "wordsA": ["Seasonality", "and", "other", "Cyclical", "Sales", "Fluctuations", "."], "wordsB": ["The", "Paonta", "Sahib", "plant", "currently", "manufactures", "product", "for", "Indian", "contract", "customers", "and", "for", "export", "to", "African,", "Asian", "and", "other", "unregulated", "markets."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_13_item1_p28_s2", "idA": "3116_12_item1_p56_s0", "sentA": "We also manufacture and distribute several controlled-drug substances, the distribution and handling of which are regulated by the DEA.", "sentB": "We currently have five patents, none of which expire within the next three years.", "type": 1, "words": ["<tag1>", "We", "also", "manufacture", "and", "distribute", "several", "controlled-drug", "substances,", "the", "distribution", "and", "handling", "of", "which", "are", "regulated", "by", "the", "DEA.", "<tag2>", "We", "currently", "have", "five", "patents,", "none", "of", "which", "expire", "within", "the", "next", "three", "years.", "<tag3>"], "wordsA": ["We", "also", "manufacture", "and", "distribute", "several", "controlled-drug", "substances,", "the", "distribution", "and", "handling", "of", "which", "are", "regulated", "by", "the", "DEA."], "wordsB": ["We", "currently", "have", "five", "patents,", "none", "of", "which", "expire", "within", "the", "next", "three", "years."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_13_item1_p52_s4", "idA": "3116_12_item1_p59_s5", "sentA": "We discontinued distribution of flu vaccines during 2009 and ceased distribution of Td vaccines as of March 14, 2010 upon the termination of our MBL Distribution Agreement.", "sentB": "In addition, late in 2012 we restarted the distribution of Td vaccines, which tends to generate higher sales in spring through fall.", "type": 1, "words": ["<tag1>", "We", "discontinued", "distribution", "of", "flu", "vaccines", "during", "2009", "and", "ceased", "distribution", "of", "Td", "vaccines", "as", "of", "March", "14,", "2010", "upon", "the", "termination", "of", "our", "MBL", "Distribution", "Agreement.", "<tag2>", "In", "addition,", "late", "in", "2012", "we", "restarted", "the", "distribution", "of", "Td", "vaccines,", "which", "tends", "to", "generate", "higher", "sales", "in", "spring", "through", "fall.", "<tag3>"], "wordsA": ["We", "discontinued", "distribution", "of", "flu", "vaccines", "during", "2009", "and", "ceased", "distribution", "of", "Td", "vaccines", "as", "of", "March", "14,", "2010", "upon", "the", "termination", "of", "our", "MBL", "Distribution", "Agreement."], "wordsB": ["In", "addition,", "late", "in", "2012", "we", "restarted", "the", "distribution", "of", "Td", "vaccines,", "which", "tends", "to", "generate", "higher", "sales", "in", "spring", "through", "fall."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_14_item1_p30_s0", "idA": "3116_13_item1_p0_s0", "sentA": "We manufacture and market a full line of diagnostic and therapeutic ophthalmic pharmaceuticals as well as niche hospital drugs and injectable pharmaceuticals.", "sentB": "This acquisition expands our line of prescription ophthalmic products to include additional branded products, and is expected to provide a platform to support future acquisitions and in-licensing of branded pharmaceuticals.", "type": 1, "words": ["<tag1>", "We", "manufacture", "and", "market", "a", "full", "line", "of", "diagnostic", "and", "therapeutic", "ophthalmic", "pharmaceuticals", "as", "well", "as", "niche", "hospital", "drugs", "and", "injectable", "pharmaceuticals.", "<tag2>", "This", "acquisition", "expands", "our", "line", "of", "prescription", "ophthalmic", "products", "to", "include", "additional", "branded", "products,", "and", "is", "expected", "to", "provide", "a", "platform", "to", "support", "future", "acquisitions", "and", "in-licensing", "of", "branded", "pharmaceuticals.", "<tag3>"], "wordsA": ["We", "manufacture", "and", "market", "a", "full", "line", "of", "diagnostic", "and", "therapeutic", "ophthalmic", "pharmaceuticals", "as", "well", "as", "niche", "hospital", "drugs", "and", "injectable", "pharmaceuticals."], "wordsB": ["This", "acquisition", "expands", "our", "line", "of", "prescription", "ophthalmic", "products", "to", "include", "additional", "branded", "products,", "and", "is", "expected", "to", "provide", "a", "platform", "to", "support", "future", "acquisitions", "and", "in-licensing", "of", "branded", "pharmaceuticals."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_14_item1_p22_s2", "idA": "3116_13_item1_p11_s4", "sentA": "We also continue to work with strategic partners for the external development of certain products.", "sentB": "JPMorgan Chase Bank, N.A. has committed financing for the transaction.", "type": 1, "words": ["<tag1>", "We", "also", "continue", "to", "work", "with", "strategic", "partners", "for", "the", "external", "development", "of", "certain", "products.", "<tag2>", "JPMorgan", "Chase", "Bank,", "N.A.", "has", "committed", "financing", "for", "the", "transaction.", "<tag3>"], "wordsA": ["We", "also", "continue", "to", "work", "with", "strategic", "partners", "for", "the", "external", "development", "of", "certain", "products."], "wordsB": ["JPMorgan", "Chase", "Bank,", "N.A.", "has", "committed", "financing", "for", "the", "transaction."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_14_item1_p29_s0", "idA": "3116_13_item1_p15_s1", "sentA": "See Government Regulation and Item 1A. Risk Factors Our growth depends on our ability to timely develop and successfully integrate new pharmaceutical products.", "sentB": "Cosopt PF a preservative-free prescription version of Cosopt, supplied in sterile, single-use containers.", "type": 1, "words": ["<tag1>", "See", "Government", "Regulation", "and", "Item", "1A.", "Risk", "Factors", "Our", "growth", "depends", "on", "our", "ability", "to", "timely", "develop", "and", "successfully", "integrate", "new", "pharmaceutical", "products.", "<tag2>", "Cosopt", "PF", "a", "preservative-free", "prescription", "version", "of", "Cosopt,", "supplied", "in", "sterile,", "single-use", "containers.", "<tag3>"], "wordsA": ["See", "Government", "Regulation", "and", "Item", "1A.", "Risk", "Factors", "Our", "growth", "depends", "on", "our", "ability", "to", "timely", "develop", "and", "successfully", "integrate", "new", "pharmaceutical", "products."], "wordsB": ["Cosopt", "PF", "a", "preservative-free", "prescription", "version", "of", "Cosopt,", "supplied", "in", "sterile,", "single-use", "containers."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_14_item1_p21_s0", "idA": "3116_13_item1_p19_s1", "sentA": "On the date of closing, of the acquisition (the Lundbeck Acquisition ), we made an initial payment of $45.0 million and will likely owe a subsequent milestone payment of $15.0 million in cash on the third anniversary of the closing date.", "sentB": "The goal of the acquisition of Hi-Tech is to strengthen Akorn s current position as the third largest company in the U.S. generic ophthalmic market and to broaden our product offering to include other niche dosage forms such as oral liquids, topical creams and ointments, nasal sprays and otics.", "type": 1, "words": ["<tag1>", "On", "the", "date", "of", "closing,", "of", "the", "acquisition", "(the", "Lundbeck", "Acquisition", "),", "we", "made", "an", "initial", "payment", "of", "$45.0", "million", "and", "will", "likely", "owe", "a", "subsequent", "milestone", "payment", "of", "$15.0", "million", "in", "cash", "on", "the", "third", "anniversary", "of", "the", "closing", "date.", "<tag2>", "The", "goal", "of", "the", "acquisition", "of", "Hi-Tech", "is", "to", "strengthen", "Akorn", "s", "current", "position", "as", "the", "third", "largest", "company", "in", "the", "U.S.", "generic", "ophthalmic", "market", "and", "to", "broaden", "our", "product", "offering", "to", "include", "other", "niche", "dosage", "forms", "such", "as", "oral", "liquids,", "topical", "creams", "and", "ointments,", "nasal", "sprays", "and", "otics.", "<tag3>"], "wordsA": ["On", "the", "date", "of", "closing,", "of", "the", "acquisition", "(the", "Lundbeck", "Acquisition", "),", "we", "made", "an", "initial", "payment", "of", "$45.0", "million", "and", "will", "likely", "owe", "a", "subsequent", "milestone", "payment", "of", "$15.0", "million", "in", "cash", "on", "the", "third", "anniversary", "of", "the", "closing", "date."], "wordsB": ["The", "goal", "of", "the", "acquisition", "of", "Hi-Tech", "is", "to", "strengthen", "Akorn", "s", "current", "position", "as", "the", "third", "largest", "company", "in", "the", "U.S.", "generic", "ophthalmic", "market", "and", "to", "broaden", "our", "product", "offering", "to", "include", "other", "niche", "dosage", "forms", "such", "as", "oral", "liquids,", "topical", "creams", "and", "ointments,", "nasal", "sprays", "and", "otics."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_14_item1_p19_s3", "idA": "3116_13_item1_p1_s0", "sentA": "Akorn, Inc. is a Louisiana corporation founded in 1971 in Abita Springs, Louisiana.", "sentB": "Upon closing, Akorn Enterprises, Inc., a wholly-owned subsidiary of Akorn, Inc., will be merged with and into Hi-Tech, which will then be a wholly-owned subsidiary of Akorn, Inc.", "type": 1, "words": ["<tag1>", "Akorn,", "Inc.", "is", "a", "Louisiana", "corporation", "founded", "in", "1971", "in", "Abita", "Springs,", "Louisiana.", "<tag2>", "Upon", "closing,", "Akorn", "Enterprises,", "Inc.,", "a", "wholly-owned", "subsidiary", "of", "Akorn,", "Inc.,", "will", "be", "merged", "with", "and", "into", "Hi-Tech,", "which", "will", "then", "be", "a", "wholly-owned", "subsidiary", "of", "Akorn,", "Inc.", "<tag3>"], "wordsA": ["Akorn,", "Inc.", "is", "a", "Louisiana", "corporation", "founded", "in", "1971", "in", "Abita", "Springs,", "Louisiana."], "wordsB": ["Upon", "closing,", "Akorn", "Enterprises,", "Inc.,", "a", "wholly-owned", "subsidiary", "of", "Akorn,", "Inc.,", "will", "be", "merged", "with", "and", "into", "Hi-Tech,", "which", "will", "then", "be", "a", "wholly-owned", "subsidiary", "of", "Akorn,", "Inc."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_14_item1_p30_s3", "idA": "3116_13_item1_p36_s0", "sentA": "We require a supply of quality raw materials and components to manufacture and package pharmaceutical products for ourselves and for third parties with which we have contracted.", "sentB": "Inspire has significant net operating loss carry-forwards, which we expect to fully utilize as an offset against our future tax liabilities.", "type": 1, "words": ["<tag1>", "We", "require", "a", "supply", "of", "quality", "raw", "materials", "and", "components", "to", "manufacture", "and", "package", "pharmaceutical", "products", "for", "ourselves", "and", "for", "third", "parties", "with", "which", "we", "have", "contracted.", "<tag2>", "Inspire", "has", "significant", "net", "operating", "loss", "carry-forwards,", "which", "we", "expect", "to", "fully", "utilize", "as", "an", "offset", "against", "our", "future", "tax", "liabilities.", "<tag3>"], "wordsA": ["We", "require", "a", "supply", "of", "quality", "raw", "materials", "and", "components", "to", "manufacture", "and", "package", "pharmaceutical", "products", "for", "ourselves", "and", "for", "third", "parties", "with", "which", "we", "have", "contracted."], "wordsB": ["Inspire", "has", "significant", "net", "operating", "loss", "carry-forwards,", "which", "we", "expect", "to", "fully", "utilize", "as", "an", "offset", "against", "our", "future", "tax", "liabilities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_14_item1_p30_s2", "idA": "3116_13_item1_p36_s4", "sentA": "The qualification of a new supplier could delay our development and marketing efforts.", "sentB": "The Merck Products Acquisition included our acquisition of a Merck subsidiary corporation, Inspire Pharmaceuticals, Inc. ( Inspire ), which was and continues to be the holder of the product rights to AzaSite .", "type": 1, "words": ["<tag1>", "The", "qualification", "of", "a", "new", "supplier", "could", "delay", "our", "development", "and", "marketing", "efforts.", "<tag2>", "The", "Merck", "Products", "Acquisition", "included", "our", "acquisition", "of", "a", "Merck", "subsidiary", "corporation,", "Inspire", "Pharmaceuticals,", "Inc.", "(", "Inspire", "),", "which", "was", "and", "continues", "to", "be", "the", "holder", "of", "the", "product", "rights", "to", "AzaSite", ".", "<tag3>"], "wordsA": ["The", "qualification", "of", "a", "new", "supplier", "could", "delay", "our", "development", "and", "marketing", "efforts."], "wordsB": ["The", "Merck", "Products", "Acquisition", "included", "our", "acquisition", "of", "a", "Merck", "subsidiary", "corporation,", "Inspire", "Pharmaceuticals,", "Inc.", "(", "Inspire", "),", "which", "was", "and", "continues", "to", "be", "the", "holder", "of", "the", "product", "rights", "to", "AzaSite", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_14_item1_p20_s0", "idA": "3116_13_item1_p42_s1", "sentA": "None of these distributors is an end user of our products.", "sentB": "Hi-Tech is a specialty pharmaceutical company that develops, manufactures and markets generic and branded prescription and OTC products.", "type": 1, "words": ["<tag1>", "None", "of", "these", "distributors", "is", "an", "end", "user", "of", "our", "products.", "<tag2>", "Hi-Tech", "is", "a", "specialty", "pharmaceutical", "company", "that", "develops,", "manufactures", "and", "markets", "generic", "and", "branded", "prescription", "and", "OTC", "products.", "<tag3>"], "wordsA": ["None", "of", "these", "distributors", "is", "an", "end", "user", "of", "our", "products."], "wordsB": ["Hi-Tech", "is", "a", "specialty", "pharmaceutical", "company", "that", "develops,", "manufactures", "and", "markets", "generic", "and", "branded", "prescription", "and", "OTC", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_14_item1_p42_s7", "idA": "3116_13_item1_p42_s1", "sentA": "None of these distributors is an end user of our products.", "sentB": "Any delays or failure of a contract manufacturing partner to supply finished goods timely or in adequate volume could impede our marketing of those products.", "type": 1, "words": ["<tag1>", "None", "of", "these", "distributors", "is", "an", "end", "user", "of", "our", "products.", "<tag2>", "Any", "delays", "or", "failure", "of", "a", "contract", "manufacturing", "partner", "to", "supply", "finished", "goods", "timely", "or", "in", "adequate", "volume", "could", "impede", "our", "marketing", "of", "those", "products.", "<tag3>"], "wordsA": ["None", "of", "these", "distributors", "is", "an", "end", "user", "of", "our", "products."], "wordsB": ["Any", "delays", "or", "failure", "of", "a", "contract", "manufacturing", "partner", "to", "supply", "finished", "goods", "timely", "or", "in", "adequate", "volume", "could", "impede", "our", "marketing", "of", "those", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_14_item1_p22_s1", "idA": "3116_13_item1_p43_s0", "sentA": "As of December 31, 2012, we had approximately $0.8 million of products on backorder as compared to approximately $2.9 million of backorders as of December 31, 2011.", "sentB": "As of January 31, 2014, Hi-Tech reported cash and cash equivalents of approximately $86 million, and we anticipate that Hi-Tech will have roughly $90 million of cash on its balance sheet at closing.", "type": 1, "words": ["<tag1>", "As", "of", "December", "31,", "2012,", "we", "had", "approximately", "$0.8", "million", "of", "products", "on", "backorder", "as", "compared", "to", "approximately", "$2.9", "million", "of", "backorders", "as", "of", "December", "31,", "2011.", "<tag2>", "As", "of", "January", "31,", "2014,", "Hi-Tech", "reported", "cash", "and", "cash", "equivalents", "of", "approximately", "$86", "million,", "and", "we", "anticipate", "that", "Hi-Tech", "will", "have", "roughly", "$90", "million", "of", "cash", "on", "its", "balance", "sheet", "at", "closing.", "<tag3>"], "wordsA": ["As", "of", "December", "31,", "2012,", "we", "had", "approximately", "$0.8", "million", "of", "products", "on", "backorder", "as", "compared", "to", "approximately", "$2.9", "million", "of", "backorders", "as", "of", "December", "31,", "2011."], "wordsB": ["As", "of", "January", "31,", "2014,", "Hi-Tech", "reported", "cash", "and", "cash", "equivalents", "of", "approximately", "$86", "million,", "and", "we", "anticipate", "that", "Hi-Tech", "will", "have", "roughly", "$90", "million", "of", "cash", "on", "its", "balance", "sheet", "at", "closing."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_14_item1_p22_s3", "idA": "3116_13_item1_p47_s1", "sentA": "Throughout the five year period ended December 31, 2012, there have been no product interruptions associated with regulatory inspection or review activities.", "sentB": "The $600 million term loan was syndicated during the quarter ended December 31, 2013, and we anticipate entering into the loan agreement once the FTC review is completed and a closing date has been set.", "type": 1, "words": ["<tag1>", "Throughout", "the", "five", "year", "period", "ended", "December", "31,", "2012,", "there", "have", "been", "no", "product", "interruptions", "associated", "with", "regulatory", "inspection", "or", "review", "activities.", "<tag2>", "The", "$600", "million", "term", "loan", "was", "syndicated", "during", "the", "quarter", "ended", "December", "31,", "2013,", "and", "we", "anticipate", "entering", "into", "the", "loan", "agreement", "once", "the", "FTC", "review", "is", "completed", "and", "a", "closing", "date", "has", "been", "set.", "<tag3>"], "wordsA": ["Throughout", "the", "five", "year", "period", "ended", "December", "31,", "2012,", "there", "have", "been", "no", "product", "interruptions", "associated", "with", "regulatory", "inspection", "or", "review", "activities."], "wordsB": ["The", "$600", "million", "term", "loan", "was", "syndicated", "during", "the", "quarter", "ended", "December", "31,", "2013,", "and", "we", "anticipate", "entering", "into", "the", "loan", "agreement", "once", "the", "FTC", "review", "is", "completed", "and", "a", "closing", "date", "has", "been", "set."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_14_item1_p22_s0", "idA": "3116_13_item1_p5_s1", "sentA": "These products are predominately sold to hospitals through the wholesale distribution channel.", "sentB": "We intend to fund the transaction principally through a $600 million term loan and through cash of Hi-Tech assumed through the acquisition.", "type": 1, "words": ["<tag1>", "These", "products", "are", "predominately", "sold", "to", "hospitals", "through", "the", "wholesale", "distribution", "channel.", "<tag2>", "We", "intend", "to", "fund", "the", "transaction", "principally", "through", "a", "$600", "million", "term", "loan", "and", "through", "cash", "of", "Hi-Tech", "assumed", "through", "the", "acquisition.", "<tag3>"], "wordsA": ["These", "products", "are", "predominately", "sold", "to", "hospitals", "through", "the", "wholesale", "distribution", "channel."], "wordsB": ["We", "intend", "to", "fund", "the", "transaction", "principally", "through", "a", "$600", "million", "term", "loan", "and", "through", "cash", "of", "Hi-Tech", "assumed", "through", "the", "acquisition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_15_item1_p34_s1", "idA": "3116_14_item1_p0_s0", "sentA": "Akorn, Inc. ( Akorn , the Company ) manufactures and markets a full line of diagnostic and therapeutic ophthalmic pharmaceuticals as well as niche hospital drugs and injectable pharmaceuticals.", "sentB": "The purpose of the Xopenex Acquisition is to expand the Company s product portfolio of prescription pharmaceuticals.", "type": 1, "words": ["<tag1>", "Akorn,", "Inc.", "(", "Akorn", ",", "the", "Company", ")", "manufactures", "and", "markets", "a", "full", "line", "of", "diagnostic", "and", "therapeutic", "ophthalmic", "pharmaceuticals", "as", "well", "as", "niche", "hospital", "drugs", "and", "injectable", "pharmaceuticals.", "<tag2>", "The", "purpose", "of", "the", "Xopenex", "Acquisition", "is", "to", "expand", "the", "Company", "s", "product", "portfolio", "of", "prescription", "pharmaceuticals.", "<tag3>"], "wordsA": ["Akorn,", "Inc.", "(", "Akorn", ",", "the", "Company", ")", "manufactures", "and", "markets", "a", "full", "line", "of", "diagnostic", "and", "therapeutic", "ophthalmic", "pharmaceuticals", "as", "well", "as", "niche", "hospital", "drugs", "and", "injectable", "pharmaceuticals."], "wordsB": ["The", "purpose", "of", "the", "Xopenex", "Acquisition", "is", "to", "expand", "the", "Company", "s", "product", "portfolio", "of", "prescription", "pharmaceuticals."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_15_item1_p34_s0", "idA": "3116_14_item1_p0_s1", "sentA": "In addition, through our subsidiary Advanced Vision Research, Inc. ( AVR ), we manufacture and market a line of over-the-counter ( OTC ) ophthalmic products for the treatment of dry eye under the TheraTears brand name, as well as a portfolio of private label OTC ophthalmic products.", "sentB": "Xopenex is indicated for the treatment or prevention of bronchospasm in adults, adolescents, and children 6 years of age and older with reversible obstructive airway disease.", "type": 1, "words": ["<tag1>", "In", "addition,", "through", "our", "subsidiary", "Advanced", "Vision", "Research,", "Inc.", "(", "AVR", "),", "we", "manufacture", "and", "market", "a", "line", "of", "over-the-counter", "(", "OTC", ")", "ophthalmic", "products", "for", "the", "treatment", "of", "dry", "eye", "under", "the", "TheraTears", "brand", "name,", "as", "well", "as", "a", "portfolio", "of", "private", "label", "OTC", "ophthalmic", "products.", "<tag2>", "Xopenex", "is", "indicated", "for", "the", "treatment", "or", "prevention", "of", "bronchospasm", "in", "adults,", "adolescents,", "and", "children", "6", "years", "of", "age", "and", "older", "with", "reversible", "obstructive", "airway", "disease.", "<tag3>"], "wordsA": ["In", "addition,", "through", "our", "subsidiary", "Advanced", "Vision", "Research,", "Inc.", "(", "AVR", "),", "we", "manufacture", "and", "market", "a", "line", "of", "over-the-counter", "(", "OTC", ")", "ophthalmic", "products", "for", "the", "treatment", "of", "dry", "eye", "under", "the", "TheraTears", "brand", "name,", "as", "well", "as", "a", "portfolio", "of", "private", "label", "OTC", "ophthalmic", "products."], "wordsB": ["Xopenex", "is", "indicated", "for", "the", "treatment", "or", "prevention", "of", "bronchospasm", "in", "adults,", "adolescents,", "and", "children", "6", "years", "of", "age", "and", "older", "with", "reversible", "obstructive", "airway", "disease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_15_item1_p20_s1", "idA": "3116_14_item1_p11_s0", "sentA": "Our national accounts sales team seeks to establish and maintain contracts with wholesalers, retail pharmacy chains and GPOs that represent hospitals in the United States.", "sentB": "VersaPharm markets its products to drug wholesalers, retail drug chains, pharmaceutical distributors, GPOs, hospitals, clinics and government agencies.", "type": 1, "words": ["<tag1>", "Our", "national", "accounts", "sales", "team", "seeks", "to", "establish", "and", "maintain", "contracts", "with", "wholesalers,", "retail", "pharmacy", "chains", "and", "GPOs", "that", "represent", "hospitals", "in", "the", "United", "States.", "<tag2>", "VersaPharm", "markets", "its", "products", "to", "drug", "wholesalers,", "retail", "drug", "chains,", "pharmaceutical", "distributors,", "GPOs,", "hospitals,", "clinics", "and", "government", "agencies.", "<tag3>"], "wordsA": ["Our", "national", "accounts", "sales", "team", "seeks", "to", "establish", "and", "maintain", "contracts", "with", "wholesalers,", "retail", "pharmacy", "chains", "and", "GPOs", "that", "represent", "hospitals", "in", "the", "United", "States."], "wordsB": ["VersaPharm", "markets", "its", "products", "to", "drug", "wholesalers,", "retail", "drug", "chains,", "pharmaceutical", "distributors,", "GPOs,", "hospitals,", "clinics", "and", "government", "agencies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_15_item1_p21_s2", "idA": "3116_14_item1_p11_s2", "sentA": "To support our sales efforts, we have a customer service team, as well as a marketing department focused on educating current and future customers about our product offerings and manufacturing capabilities.", "sentB": "Through which the Company acquired manufacturing capabilities needed for many of VersaPharm s current and pipeline products.", "type": 1, "words": ["<tag1>", "To", "support", "our", "sales", "efforts,", "we", "have", "a", "customer", "service", "team,", "as", "well", "as", "a", "marketing", "department", "focused", "on", "educating", "current", "and", "future", "customers", "about", "our", "product", "offerings", "and", "manufacturing", "capabilities.", "<tag2>", "Through", "which", "the", "Company", "acquired", "manufacturing", "capabilities", "needed", "for", "many", "of", "VersaPharm", "s", "current", "and", "pipeline", "products.", "<tag3>"], "wordsA": ["To", "support", "our", "sales", "efforts,", "we", "have", "a", "customer", "service", "team,", "as", "well", "as", "a", "marketing", "department", "focused", "on", "educating", "current", "and", "future", "customers", "about", "our", "product", "offerings", "and", "manufacturing", "capabilities."], "wordsB": ["Through", "which", "the", "Company", "acquired", "manufacturing", "capabilities", "needed", "for", "many", "of", "VersaPharm", "s", "current", "and", "pipeline", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_15_item1_p21_s3", "idA": "3116_14_item1_p12_s3", "sentA": "We believe that having our own centralized and dedicated R D facility allows us to significantly increase the size of our product pipeline as well as shorten the time between project launch and filing with the FDA.", "sentB": "The VersaPharm Acquisition also enhances the Company s new product pipeline as VersaPharm has significant R D experience and knowledge and numerous in-process research and development ( IPR D ) products are under active development.", "type": 1, "words": ["<tag1>", "We", "believe", "that", "having", "our", "own", "centralized", "and", "dedicated", "R", "D", "facility", "allows", "us", "to", "significantly", "increase", "the", "size", "of", "our", "product", "pipeline", "as", "well", "as", "shorten", "the", "time", "between", "project", "launch", "and", "filing", "with", "the", "FDA.", "<tag2>", "The", "VersaPharm", "Acquisition", "also", "enhances", "the", "Company", "s", "new", "product", "pipeline", "as", "VersaPharm", "has", "significant", "R", "D", "experience", "and", "knowledge", "and", "numerous", "in-process", "research", "and", "development", "(", "IPR", "D", ")", "products", "are", "under", "active", "development.", "<tag3>"], "wordsA": ["We", "believe", "that", "having", "our", "own", "centralized", "and", "dedicated", "R", "D", "facility", "allows", "us", "to", "significantly", "increase", "the", "size", "of", "our", "product", "pipeline", "as", "well", "as", "shorten", "the", "time", "between", "project", "launch", "and", "filing", "with", "the", "FDA."], "wordsB": ["The", "VersaPharm", "Acquisition", "also", "enhances", "the", "Company", "s", "new", "product", "pipeline", "as", "VersaPharm", "has", "significant", "R", "D", "experience", "and", "knowledge", "and", "numerous", "in-process", "research", "and", "development", "(", "IPR", "D", ")", "products", "are", "under", "active", "development."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_15_item1_p33_s1", "idA": "3116_14_item1_p12_s4", "sentA": "We also continue to work with strategic partners for the external development of certain products.", "sentB": "The purchase price for the acquisition was $45.0 million, funded through available cash paid at closing, net of certain liabilities for product return reserves, rebates, and chargeback reserves, which were assumed by Oak Pharmaceuticals, Inc. ( Oak ), a subsidiary of Akorn, subject to a cap.", "type": 1, "words": ["<tag1>", "We", "also", "continue", "to", "work", "with", "strategic", "partners", "for", "the", "external", "development", "of", "certain", "products.", "<tag2>", "The", "purchase", "price", "for", "the", "acquisition", "was", "$45.0", "million,", "funded", "through", "available", "cash", "paid", "at", "closing,", "net", "of", "certain", "liabilities", "for", "product", "return", "reserves,", "rebates,", "and", "chargeback", "reserves,", "which", "were", "assumed", "by", "Oak", "Pharmaceuticals,", "Inc.", "(", "Oak", "),", "a", "subsidiary", "of", "Akorn,", "subject", "to", "a", "cap.", "<tag3>"], "wordsA": ["We", "also", "continue", "to", "work", "with", "strategic", "partners", "for", "the", "external", "development", "of", "certain", "products."], "wordsB": ["The", "purchase", "price", "for", "the", "acquisition", "was", "$45.0", "million,", "funded", "through", "available", "cash", "paid", "at", "closing,", "net", "of", "certain", "liabilities", "for", "product", "return", "reserves,", "rebates,", "and", "chargeback", "reserves,", "which", "were", "assumed", "by", "Oak", "Pharmaceuticals,", "Inc.", "(", "Oak", "),", "a", "subsidiary", "of", "Akorn,", "subject", "to", "a", "cap."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_15_item1_p32_s2", "idA": "3116_14_item1_p18_s0", "sentA": "We actively seek to expand and enhance our business through strategic acquisitions.", "sentB": "The purpose of the Lloyd Products acquisition is to expand the Company s animal health product portfolio.", "type": 1, "words": ["<tag1>", "We", "actively", "seek", "to", "expand", "and", "enhance", "our", "business", "through", "strategic", "acquisitions.", "<tag2>", "The", "purpose", "of", "the", "Lloyd", "Products", "acquisition", "is", "to", "expand", "the", "Company", "s", "animal", "health", "product", "portfolio.", "<tag3>"], "wordsA": ["We", "actively", "seek", "to", "expand", "and", "enhance", "our", "business", "through", "strategic", "acquisitions."], "wordsB": ["The", "purpose", "of", "the", "Lloyd", "Products", "acquisition", "is", "to", "expand", "the", "Company", "s", "animal", "health", "product", "portfolio."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_15_item1_p37_s1", "idA": "3116_14_item1_p18_s0", "sentA": "We actively seek to expand and enhance our business through strategic acquisitions.", "sentB": "The purpose of the Betimol Acquisition is to expand the Company s product portfolio of branded prescription pharmaceuticals indicated for ophthalmology.", "type": 1, "words": ["<tag1>", "We", "actively", "seek", "to", "expand", "and", "enhance", "our", "business", "through", "strategic", "acquisitions.", "<tag2>", "The", "purpose", "of", "the", "Betimol", "Acquisition", "is", "to", "expand", "the", "Company", "s", "product", "portfolio", "of", "branded", "prescription", "pharmaceuticals", "indicated", "for", "ophthalmology.", "<tag3>"], "wordsA": ["We", "actively", "seek", "to", "expand", "and", "enhance", "our", "business", "through", "strategic", "acquisitions."], "wordsB": ["The", "purpose", "of", "the", "Betimol", "Acquisition", "is", "to", "expand", "the", "Company", "s", "product", "portfolio", "of", "branded", "prescription", "pharmaceuticals", "indicated", "for", "ophthalmology."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_15_item1_p16_s0", "idA": "3116_14_item1_p19_s0", "sentA": "On August 27, 2013, we entered into a definitive agreement to acquire Hi-Tech Pharmacal Co, Inc. ( Hi-Tech ) for a total purchase price of approximately $640 million, or $43.50 per outstanding share of Hi-Tech common stock.", "sentB": "On July 22, 2014, our Luxembourg subsidiary, Akorn International S. r.l., entered into a share purchase agreement with Fareva SA, to acquire all of the issued and outstanding shares of capital stock of Excelvision AG, a Swiss Company ( Excelvision ) for 21.7 million Swiss Francs ( CHF ), net of certain working capital amounts.", "type": 1, "words": ["<tag1>", "On", "August", "27,", "2013,", "we", "entered", "into", "a", "definitive", "agreement", "to", "acquire", "Hi-Tech", "Pharmacal", "Co,", "Inc.", "(", "Hi-Tech", ")", "for", "a", "total", "purchase", "price", "of", "approximately", "$640", "million,", "or", "$43.50", "per", "outstanding", "share", "of", "Hi-Tech", "common", "stock.", "<tag2>", "On", "July", "22,", "2014,", "our", "Luxembourg", "subsidiary,", "Akorn", "International", "S.", "r.l.,", "entered", "into", "a", "share", "purchase", "agreement", "with", "Fareva", "SA,", "to", "acquire", "all", "of", "the", "issued", "and", "outstanding", "shares", "of", "capital", "stock", "of", "Excelvision", "AG,", "a", "Swiss", "Company", "(", "Excelvision", ")", "for", "21.7", "million", "Swiss", "Francs", "(", "CHF", "),", "net", "of", "certain", "working", "capital", "amounts.", "<tag3>"], "wordsA": ["On", "August", "27,", "2013,", "we", "entered", "into", "a", "definitive", "agreement", "to", "acquire", "Hi-Tech", "Pharmacal", "Co,", "Inc.", "(", "Hi-Tech", ")", "for", "a", "total", "purchase", "price", "of", "approximately", "$640", "million,", "or", "$43.50", "per", "outstanding", "share", "of", "Hi-Tech", "common", "stock."], "wordsB": ["On", "July", "22,", "2014,", "our", "Luxembourg", "subsidiary,", "Akorn", "International", "S.", "r.l.,", "entered", "into", "a", "share", "purchase", "agreement", "with", "Fareva", "SA,", "to", "acquire", "all", "of", "the", "issued", "and", "outstanding", "shares", "of", "capital", "stock", "of", "Excelvision", "AG,", "a", "Swiss", "Company", "(", "Excelvision", ")", "for", "21.7", "million", "Swiss", "Francs", "(", "CHF", "),", "net", "of", "certain", "working", "capital", "amounts."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_15_item1_p18_s1", "idA": "3116_14_item1_p19_s0", "sentA": "On August 27, 2013, we entered into a definitive agreement to acquire Hi-Tech Pharmacal Co, Inc. ( Hi-Tech ) for a total purchase price of approximately $640 million, or $43.50 per outstanding share of Hi-Tech common stock.", "sentB": "On May 9, 2014, the Company had entered into an Agreement and Plan of Merger (the VP Merger Agreement ) to acquire VPI Holdings Corp. ( VPI ), the parent company of VersaPharm.", "type": 1, "words": ["<tag1>", "On", "August", "27,", "2013,", "we", "entered", "into", "a", "definitive", "agreement", "to", "acquire", "Hi-Tech", "Pharmacal", "Co,", "Inc.", "(", "Hi-Tech", ")", "for", "a", "total", "purchase", "price", "of", "approximately", "$640", "million,", "or", "$43.50", "per", "outstanding", "share", "of", "Hi-Tech", "common", "stock.", "<tag2>", "On", "May", "9,", "2014,", "the", "Company", "had", "entered", "into", "an", "Agreement", "and", "Plan", "of", "Merger", "(the", "VP", "Merger", "Agreement", ")", "to", "acquire", "VPI", "Holdings", "Corp.", "(", "VPI", "),", "the", "parent", "company", "of", "VersaPharm.", "<tag3>"], "wordsA": ["On", "August", "27,", "2013,", "we", "entered", "into", "a", "definitive", "agreement", "to", "acquire", "Hi-Tech", "Pharmacal", "Co,", "Inc.", "(", "Hi-Tech", ")", "for", "a", "total", "purchase", "price", "of", "approximately", "$640", "million,", "or", "$43.50", "per", "outstanding", "share", "of", "Hi-Tech", "common", "stock."], "wordsB": ["On", "May", "9,", "2014,", "the", "Company", "had", "entered", "into", "an", "Agreement", "and", "Plan", "of", "Merger", "(the", "VP", "Merger", "Agreement", ")", "to", "acquire", "VPI", "Holdings", "Corp.", "(", "VPI", "),", "the", "parent", "company", "of", "VersaPharm."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_15_item1_p17_s0", "idA": "3116_14_item1_p19_s1", "sentA": "The acquisition was approved by vote of the shareholders of Hi-Tech on December 19, 2013, but is still subject to review by the Federal Trade Commission pursuant to provisions of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended.", "sentB": "The acquisition was completed on January 2, 2015 upon payment of the previously-agreed to consideration, which equated to $25.9 million U.S. dollars, and was funded through available cash on hand.", "type": 1, "words": ["<tag1>", "The", "acquisition", "was", "approved", "by", "vote", "of", "the", "shareholders", "of", "Hi-Tech", "on", "December", "19,", "2013,", "but", "is", "still", "subject", "to", "review", "by", "the", "Federal", "Trade", "Commission", "pursuant", "to", "provisions", "of", "the", "Hart-Scott-Rodino", "Antitrust", "Improvements", "Act", "of", "1976,", "as", "amended.", "<tag2>", "The", "acquisition", "was", "completed", "on", "January", "2,", "2015", "upon", "payment", "of", "the", "previously-agreed", "to", "consideration,", "which", "equated", "to", "$25.9", "million", "U.S.", "dollars,", "and", "was", "funded", "through", "available", "cash", "on", "hand.", "<tag3>"], "wordsA": ["The", "acquisition", "was", "approved", "by", "vote", "of", "the", "shareholders", "of", "Hi-Tech", "on", "December", "19,", "2013,", "but", "is", "still", "subject", "to", "review", "by", "the", "Federal", "Trade", "Commission", "pursuant", "to", "provisions", "of", "the", "Hart-Scott-Rodino", "Antitrust", "Improvements", "Act", "of", "1976,", "as", "amended."], "wordsB": ["The", "acquisition", "was", "completed", "on", "January", "2,", "2015", "upon", "payment", "of", "the", "previously-agreed", "to", "consideration,", "which", "equated", "to", "$25.9", "million", "U.S.", "dollars,", "and", "was", "funded", "through", "available", "cash", "on", "hand."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_15_item1_p37_s3", "idA": "3116_14_item1_p19_s2", "sentA": "We expect the acquisition to close early in the second quarter of 2014.", "sentB": "The Company paid a non-refundable amount of $7.5 million upon completing the acquisition and will pay any remaining amount 60 days following the first year post-acquisition.", "type": 1, "words": ["<tag1>", "We", "expect", "the", "acquisition", "to", "close", "early", "in", "the", "second", "quarter", "of", "2014.", "<tag2>", "The", "Company", "paid", "a", "non-refundable", "amount", "of", "$7.5", "million", "upon", "completing", "the", "acquisition", "and", "will", "pay", "any", "remaining", "amount", "60", "days", "following", "the", "first", "year", "post-acquisition.", "<tag3>"], "wordsA": ["We", "expect", "the", "acquisition", "to", "close", "early", "in", "the", "second", "quarter", "of", "2014."], "wordsB": ["The", "Company", "paid", "a", "non-refundable", "amount", "of", "$7.5", "million", "upon", "completing", "the", "acquisition", "and", "will", "pay", "any", "remaining", "amount", "60", "days", "following", "the", "first", "year", "post-acquisition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_15_item1_p23_s0", "idA": "3116_14_item1_p19_s3", "sentA": "Upon closing, Akorn Enterprises, Inc., a wholly-owned subsidiary of Akorn, Inc., will be merged with and into Hi-Tech, which will then be a wholly-owned subsidiary of Akorn, Inc.", "sentB": "Hi-Tech Pharmacal Co., Inc., Acquisition :", "type": 1, "words": ["<tag1>", "Upon", "closing,", "Akorn", "Enterprises,", "Inc.,", "a", "wholly-owned", "subsidiary", "of", "Akorn,", "Inc.,", "will", "be", "merged", "with", "and", "into", "Hi-Tech,", "which", "will", "then", "be", "a", "wholly-owned", "subsidiary", "of", "Akorn,", "Inc.", "<tag2>", "Hi-Tech", "Pharmacal", "Co.,", "Inc.,", "Acquisition", ":", "<tag3>"], "wordsA": ["Upon", "closing,", "Akorn", "Enterprises,", "Inc.,", "a", "wholly-owned", "subsidiary", "of", "Akorn,", "Inc.,", "will", "be", "merged", "with", "and", "into", "Hi-Tech,", "which", "will", "then", "be", "a", "wholly-owned", "subsidiary", "of", "Akorn,", "Inc."], "wordsB": ["Hi-Tech", "Pharmacal", "Co.,", "Inc.,", "Acquisition", ":"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_15_item1_p25_s0", "idA": "3116_14_item1_p19_s3", "sentA": "Upon closing, Akorn Enterprises, Inc., a wholly-owned subsidiary of Akorn, Inc., will be merged with and into Hi-Tech, which will then be a wholly-owned subsidiary of Akorn, Inc.", "sentB": "In connection with the Hi-Tech Acquisition, the Company entered into an agreement (the Divestment Agreement ) with Watson Laboratories, Inc., a wholly owned subsidiary of Actavis plc, to divest certain rights and assets, as further described below in Note 16, Business Combinations, Dispositions and Other Strategic Investments .", "type": 1, "words": ["<tag1>", "Upon", "closing,", "Akorn", "Enterprises,", "Inc.,", "a", "wholly-owned", "subsidiary", "of", "Akorn,", "Inc.,", "will", "be", "merged", "with", "and", "into", "Hi-Tech,", "which", "will", "then", "be", "a", "wholly-owned", "subsidiary", "of", "Akorn,", "Inc.", "<tag2>", "In", "connection", "with", "the", "Hi-Tech", "Acquisition,", "the", "Company", "entered", "into", "an", "agreement", "(the", "Divestment", "Agreement", ")", "with", "Watson", "Laboratories,", "Inc.,", "a", "wholly", "owned", "subsidiary", "of", "Actavis", "plc,", "to", "divest", "certain", "rights", "and", "assets,", "as", "further", "described", "below", "in", "Note", "16,", "Business", "Combinations,", "Dispositions", "and", "Other", "Strategic", "Investments", ".", "<tag3>"], "wordsA": ["Upon", "closing,", "Akorn", "Enterprises,", "Inc.,", "a", "wholly-owned", "subsidiary", "of", "Akorn,", "Inc.,", "will", "be", "merged", "with", "and", "into", "Hi-Tech,", "which", "will", "then", "be", "a", "wholly-owned", "subsidiary", "of", "Akorn,", "Inc."], "wordsB": ["In", "connection", "with", "the", "Hi-Tech", "Acquisition,", "the", "Company", "entered", "into", "an", "agreement", "(the", "Divestment", "Agreement", ")", "with", "Watson", "Laboratories,", "Inc.,", "a", "wholly", "owned", "subsidiary", "of", "Actavis", "plc,", "to", "divest", "certain", "rights", "and", "assets,", "as", "further", "described", "below", "in", "Note", "16,", "Business", "Combinations,", "Dispositions", "and", "Other", "Strategic", "Investments", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_15_item1_p0_s1", "idA": "3116_14_item1_p21_s0", "sentA": "The goal of the acquisition of Hi-Tech is to strengthen Akorn s current position as the third largest company in the U.S. generic ophthalmic market and to broaden our product offering to include other niche dosage forms such as oral liquids, topical creams and ointments, nasal sprays and otics.", "sentB": "We specialize in difficult-to-manufacture sterile and non-sterile dosage forms including: ophthalmics, injectables, oral liquids, otics, topicals, inhalants, and nasal sprays.", "type": 1, "words": ["<tag1>", "The", "goal", "of", "the", "acquisition", "of", "Hi-Tech", "is", "to", "strengthen", "Akorn", "s", "current", "position", "as", "the", "third", "largest", "company", "in", "the", "U.S.", "generic", "ophthalmic", "market", "and", "to", "broaden", "our", "product", "offering", "to", "include", "other", "niche", "dosage", "forms", "such", "as", "oral", "liquids,", "topical", "creams", "and", "ointments,", "nasal", "sprays", "and", "otics.", "<tag2>", "We", "specialize", "in", "difficult-to-manufacture", "sterile", "and", "non-sterile", "dosage", "forms", "including:", "ophthalmics,", "injectables,", "oral", "liquids,", "otics,", "topicals,", "inhalants,", "and", "nasal", "sprays.", "<tag3>"], "wordsA": ["The", "goal", "of", "the", "acquisition", "of", "Hi-Tech", "is", "to", "strengthen", "Akorn", "s", "current", "position", "as", "the", "third", "largest", "company", "in", "the", "U.S.", "generic", "ophthalmic", "market", "and", "to", "broaden", "our", "product", "offering", "to", "include", "other", "niche", "dosage", "forms", "such", "as", "oral", "liquids,", "topical", "creams", "and", "ointments,", "nasal", "sprays", "and", "otics."], "wordsB": ["We", "specialize", "in", "difficult-to-manufacture", "sterile", "and", "non-sterile", "dosage", "forms", "including:", "ophthalmics,", "injectables,", "oral", "liquids,", "otics,", "topicals,", "inhalants,", "and", "nasal", "sprays."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_15_item1_p35_s2", "idA": "3116_14_item1_p21_s0", "sentA": "The goal of the acquisition of Hi-Tech is to strengthen Akorn s current position as the third largest company in the U.S. generic ophthalmic market and to broaden our product offering to include other niche dosage forms such as oral liquids, topical creams and ointments, nasal sprays and otics.", "sentB": "The purpose of the acquisition is to expand the Company s product portfolio of branded prescription pharmaceuticals indicated for ophthalmology.", "type": 1, "words": ["<tag1>", "The", "goal", "of", "the", "acquisition", "of", "Hi-Tech", "is", "to", "strengthen", "Akorn", "s", "current", "position", "as", "the", "third", "largest", "company", "in", "the", "U.S.", "generic", "ophthalmic", "market", "and", "to", "broaden", "our", "product", "offering", "to", "include", "other", "niche", "dosage", "forms", "such", "as", "oral", "liquids,", "topical", "creams", "and", "ointments,", "nasal", "sprays", "and", "otics.", "<tag2>", "The", "purpose", "of", "the", "acquisition", "is", "to", "expand", "the", "Company", "s", "product", "portfolio", "of", "branded", "prescription", "pharmaceuticals", "indicated", "for", "ophthalmology.", "<tag3>"], "wordsA": ["The", "goal", "of", "the", "acquisition", "of", "Hi-Tech", "is", "to", "strengthen", "Akorn", "s", "current", "position", "as", "the", "third", "largest", "company", "in", "the", "U.S.", "generic", "ophthalmic", "market", "and", "to", "broaden", "our", "product", "offering", "to", "include", "other", "niche", "dosage", "forms", "such", "as", "oral", "liquids,", "topical", "creams", "and", "ointments,", "nasal", "sprays", "and", "otics."], "wordsB": ["The", "purpose", "of", "the", "acquisition", "is", "to", "expand", "the", "Company", "s", "product", "portfolio", "of", "branded", "prescription", "pharmaceuticals", "indicated", "for", "ophthalmology."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_15_item1_p67_s3", "idA": "3116_14_item1_p21_s0", "sentA": "The goal of the acquisition of Hi-Tech is to strengthen Akorn s current position as the third largest company in the U.S. generic ophthalmic market and to broaden our product offering to include other niche dosage forms such as oral liquids, topical creams and ointments, nasal sprays and otics.", "sentB": "The declining revenue generated by AIPL through the respective periods is principally the result of the Company s decision to reduce revenues associated with comparatively low-margin contract manufacturing to focus on achieving U.S. FDA site approval.", "type": 1, "words": ["<tag1>", "The", "goal", "of", "the", "acquisition", "of", "Hi-Tech", "is", "to", "strengthen", "Akorn", "s", "current", "position", "as", "the", "third", "largest", "company", "in", "the", "U.S.", "generic", "ophthalmic", "market", "and", "to", "broaden", "our", "product", "offering", "to", "include", "other", "niche", "dosage", "forms", "such", "as", "oral", "liquids,", "topical", "creams", "and", "ointments,", "nasal", "sprays", "and", "otics.", "<tag2>", "The", "declining", "revenue", "generated", "by", "AIPL", "through", "the", "respective", "periods", "is", "principally", "the", "result", "of", "the", "Company", "s", "decision", "to", "reduce", "revenues", "associated", "with", "comparatively", "low-margin", "contract", "manufacturing", "to", "focus", "on", "achieving", "U.S.", "FDA", "site", "approval.", "<tag3>"], "wordsA": ["The", "goal", "of", "the", "acquisition", "of", "Hi-Tech", "is", "to", "strengthen", "Akorn", "s", "current", "position", "as", "the", "third", "largest", "company", "in", "the", "U.S.", "generic", "ophthalmic", "market", "and", "to", "broaden", "our", "product", "offering", "to", "include", "other", "niche", "dosage", "forms", "such", "as", "oral", "liquids,", "topical", "creams", "and", "ointments,", "nasal", "sprays", "and", "otics."], "wordsB": ["The", "declining", "revenue", "generated", "by", "AIPL", "through", "the", "respective", "periods", "is", "principally", "the", "result", "of", "the", "Company", "s", "decision", "to", "reduce", "revenues", "associated", "with", "comparatively", "low-margin", "contract", "manufacturing", "to", "focus", "on", "achieving", "U.S.", "FDA", "site", "approval."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_15_item1_p37_s4", "idA": "3116_14_item1_p22_s0", "sentA": "We intend to fund the transaction principally through a $600 million term loan and through cash of Hi-Tech assumed through the acquisition.", "sentB": "There is also a provision for a $2.0 million increase to the total consideration should net sales of Betimol exceed a sizable threshold in any one of the first five years following the acquisition.", "type": 1, "words": ["<tag1>", "We", "intend", "to", "fund", "the", "transaction", "principally", "through", "a", "$600", "million", "term", "loan", "and", "through", "cash", "of", "Hi-Tech", "assumed", "through", "the", "acquisition.", "<tag2>", "There", "is", "also", "a", "provision", "for", "a", "$2.0", "million", "increase", "to", "the", "total", "consideration", "should", "net", "sales", "of", "Betimol", "exceed", "a", "sizable", "threshold", "in", "any", "one", "of", "the", "first", "five", "years", "following", "the", "acquisition.", "<tag3>"], "wordsA": ["We", "intend", "to", "fund", "the", "transaction", "principally", "through", "a", "$600", "million", "term", "loan", "and", "through", "cash", "of", "Hi-Tech", "assumed", "through", "the", "acquisition."], "wordsB": ["There", "is", "also", "a", "provision", "for", "a", "$2.0", "million", "increase", "to", "the", "total", "consideration", "should", "net", "sales", "of", "Betimol", "exceed", "a", "sizable", "threshold", "in", "any", "one", "of", "the", "first", "five", "years", "following", "the", "acquisition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_15_item1_p21_s0", "idA": "3116_14_item1_p24_s0", "sentA": "The Paonta Sahib plant currently manufactures pharmaceutical products primarily for contract customers in India and for export to unregulated markets.", "sentB": "The VersaPharm Acquisition complements and expands the Company s product portfolio by diversifying its offering to niche dermatology markets.", "type": 1, "words": ["<tag1>", "The", "Paonta", "Sahib", "plant", "currently", "manufactures", "pharmaceutical", "products", "primarily", "for", "contract", "customers", "in", "India", "and", "for", "export", "to", "unregulated", "markets.", "<tag2>", "The", "VersaPharm", "Acquisition", "complements", "and", "expands", "the", "Company", "s", "product", "portfolio", "by", "diversifying", "its", "offering", "to", "niche", "dermatology", "markets.", "<tag3>"], "wordsA": ["The", "Paonta", "Sahib", "plant", "currently", "manufactures", "pharmaceutical", "products", "primarily", "for", "contract", "customers", "in", "India", "and", "for", "export", "to", "unregulated", "markets."], "wordsB": ["The", "VersaPharm", "Acquisition", "complements", "and", "expands", "the", "Company", "s", "product", "portfolio", "by", "diversifying", "its", "offering", "to", "niche", "dermatology", "markets."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_15_item1_p27_s2", "idA": "3116_14_item1_p26_s0", "sentA": "AVR is a developer and marketer of a line of OTC eye care products marketed primarily under the TheraTears brand name.", "sentB": "Further, the Hi-Tech Acquisition adds branded OTC products in the categories of cough and cold, nasals, and topicals to the Company s TheraTears brand of eye care products, and provides additional domestic manufacturing capacity for the Company.", "type": 1, "words": ["<tag1>", "AVR", "is", "a", "developer", "and", "marketer", "of", "a", "line", "of", "OTC", "eye", "care", "products", "marketed", "primarily", "under", "the", "TheraTears", "brand", "name.", "<tag2>", "Further,", "the", "Hi-Tech", "Acquisition", "adds", "branded", "OTC", "products", "in", "the", "categories", "of", "cough", "and", "cold,", "nasals,", "and", "topicals", "to", "the", "Company", "s", "TheraTears", "brand", "of", "eye", "care", "products,", "and", "provides", "additional", "domestic", "manufacturing", "capacity", "for", "the", "Company.", "<tag3>"], "wordsA": ["AVR", "is", "a", "developer", "and", "marketer", "of", "a", "line", "of", "OTC", "eye", "care", "products", "marketed", "primarily", "under", "the", "TheraTears", "brand", "name."], "wordsB": ["Further,", "the", "Hi-Tech", "Acquisition", "adds", "branded", "OTC", "products", "in", "the", "categories", "of", "cough", "and", "cold,", "nasals,", "and", "topicals", "to", "the", "Company", "s", "TheraTears", "brand", "of", "eye", "care", "products,", "and", "provides", "additional", "domestic", "manufacturing", "capacity", "for", "the", "Company."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_15_item1_p5_s1", "idA": "3116_14_item1_p32_s0", "sentA": "The acquired portfolio consists of Nembutal , a Schedule II controlled drug, Diuril and Cogentin .", "sentB": "Branded marketed products include, among others, Akten , a topical ocular anesthetic gel, AzaSite , an antibiotic used to treat bacterial conjunctivitis, Cosopt , Cosopt PF, Betimol and Zioptan , which are used in the treatment of glaucoma, Nembutal , which is a sedative, and Xopenex Inhalation Solution, which is used in the treatment or prevention of bronchospasm.", "type": 1, "words": ["<tag1>", "The", "acquired", "portfolio", "consists", "of", "Nembutal", ",", "a", "Schedule", "II", "controlled", "drug,", "Diuril", "and", "Cogentin", ".", "<tag2>", "Branded", "marketed", "products", "include,", "among", "others,", "Akten", ",", "a", "topical", "ocular", "anesthetic", "gel,", "AzaSite", ",", "an", "antibiotic", "used", "to", "treat", "bacterial", "conjunctivitis,", "Cosopt", ",", "Cosopt", "PF,", "Betimol", "and", "Zioptan", ",", "which", "are", "used", "in", "the", "treatment", "of", "glaucoma,", "Nembutal", ",", "which", "is", "a", "sedative,", "and", "Xopenex", "Inhalation", "Solution,", "which", "is", "used", "in", "the", "treatment", "or", "prevention", "of", "bronchospasm.", "<tag3>"], "wordsA": ["The", "acquired", "portfolio", "consists", "of", "Nembutal", ",", "a", "Schedule", "II", "controlled", "drug,", "Diuril", "and", "Cogentin", "."], "wordsB": ["Branded", "marketed", "products", "include,", "among", "others,", "Akten", ",", "a", "topical", "ocular", "anesthetic", "gel,", "AzaSite", ",", "an", "antibiotic", "used", "to", "treat", "bacterial", "conjunctivitis,", "Cosopt", ",", "Cosopt", "PF,", "Betimol", "and", "Zioptan", ",", "which", "are", "used", "in", "the", "treatment", "of", "glaucoma,", "Nembutal", ",", "which", "is", "a", "sedative,", "and", "Xopenex", "Inhalation", "Solution,", "which", "is", "used", "in", "the", "treatment", "or", "prevention", "of", "bronchospasm."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_15_item1_p6_s3", "idA": "3116_14_item1_p34_s2", "sentA": "One of our acquired companies, AVR, maintains a line of OTC eye care products sold under trade names such as TheraTears and SteriLid , among others.", "sentB": "The segment also includes animal health branded and generic products such as Anased , Tolazine , Yobine , Butorphic and VetaKet .", "type": 1, "words": ["<tag1>", "One", "of", "our", "acquired", "companies,", "AVR,", "maintains", "a", "line", "of", "OTC", "eye", "care", "products", "sold", "under", "trade", "names", "such", "as", "TheraTears", "and", "SteriLid", ",", "among", "others.", "<tag2>", "The", "segment", "also", "includes", "animal", "health", "branded", "and", "generic", "products", "such", "as", "Anased", ",", "Tolazine", ",", "Yobine", ",", "Butorphic", "and", "VetaKet", ".", "<tag3>"], "wordsA": ["One", "of", "our", "acquired", "companies,", "AVR,", "maintains", "a", "line", "of", "OTC", "eye", "care", "products", "sold", "under", "trade", "names", "such", "as", "TheraTears", "and", "SteriLid", ",", "among", "others."], "wordsB": ["The", "segment", "also", "includes", "animal", "health", "branded", "and", "generic", "products", "such", "as", "Anased", ",", "Tolazine", ",", "Yobine", ",", "Butorphic", "and", "VetaKet", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_15_item1_p35_s0", "idA": "3116_14_item1_p34_s4", "sentA": "Through the Merck Products Acquisition, we also acquired rights to the trade names for the branded, prescription ophthalmic products AzaSite and Cosopt .", "sentB": "On April 1, 2014, the Company acquired from Merck, Sharp and Dohme Corp. ( Merck ) the U.S. NDA rights to Zioptan , a prescription ophthalmic eye drop indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension, from Merck, Sharp and Dohme Corp. ( Merck ).", "type": 1, "words": ["<tag1>", "Through", "the", "Merck", "Products", "Acquisition,", "we", "also", "acquired", "rights", "to", "the", "trade", "names", "for", "the", "branded,", "prescription", "ophthalmic", "products", "AzaSite", "and", "Cosopt", ".", "<tag2>", "On", "April", "1,", "2014,", "the", "Company", "acquired", "from", "Merck,", "Sharp", "and", "Dohme", "Corp.", "(", "Merck", ")", "the", "U.S.", "NDA", "rights", "to", "Zioptan", ",", "a", "prescription", "ophthalmic", "eye", "drop", "indicated", "for", "reducing", "elevated", "intraocular", "pressure", "in", "patients", "with", "open-angle", "glaucoma", "or", "ocular", "hypertension,", "from", "Merck,", "Sharp", "and", "Dohme", "Corp.", "(", "Merck", ").", "<tag3>"], "wordsA": ["Through", "the", "Merck", "Products", "Acquisition,", "we", "also", "acquired", "rights", "to", "the", "trade", "names", "for", "the", "branded,", "prescription", "ophthalmic", "products", "AzaSite", "and", "Cosopt", "."], "wordsB": ["On", "April", "1,", "2014,", "the", "Company", "acquired", "from", "Merck,", "Sharp", "and", "Dohme", "Corp.", "(", "Merck", ")", "the", "U.S.", "NDA", "rights", "to", "Zioptan", ",", "a", "prescription", "ophthalmic", "eye", "drop", "indicated", "for", "reducing", "elevated", "intraocular", "pressure", "in", "patients", "with", "open-angle", "glaucoma", "or", "ocular", "hypertension,", "from", "Merck,", "Sharp", "and", "Dohme", "Corp.", "(", "Merck", ")."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_15_item1_p68_s1", "idA": "3116_14_item1_p35_s1", "sentA": "The importance of these patents does not vary among our business segments.", "sentB": "The Company does not regard these risks as a deterrent to further expansion of its operations abroad.", "type": 1, "words": ["<tag1>", "The", "importance", "of", "these", "patents", "does", "not", "vary", "among", "our", "business", "segments.", "<tag2>", "The", "Company", "does", "not", "regard", "these", "risks", "as", "a", "deterrent", "to", "further", "expansion", "of", "its", "operations", "abroad.", "<tag3>"], "wordsA": ["The", "importance", "of", "these", "patents", "does", "not", "vary", "among", "our", "business", "segments."], "wordsB": ["The", "Company", "does", "not", "regard", "these", "risks", "as", "a", "deterrent", "to", "further", "expansion", "of", "its", "operations", "abroad."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_15_item1_p70_s1", "idA": "3116_14_item1_p49_s1", "sentA": "None of these distributors is an end user of our products.", "sentB": "A number of these contracts allow the Government to terminate upon written notice.", "type": 1, "words": ["<tag1>", "None", "of", "these", "distributors", "is", "an", "end", "user", "of", "our", "products.", "<tag2>", "A", "number", "of", "these", "contracts", "allow", "the", "Government", "to", "terminate", "upon", "written", "notice.", "<tag3>"], "wordsA": ["None", "of", "these", "distributors", "is", "an", "end", "user", "of", "our", "products."], "wordsB": ["A", "number", "of", "these", "contracts", "allow", "the", "Government", "to", "terminate", "upon", "written", "notice."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_15_item1_p68_s2", "idA": "3116_14_item1_p49_s3", "sentA": "However, the loss of one or more of these distributors, together with a delay or inability to secure an alternative distribution source for end users, could have a material negative impact on our revenue, business, financial condition and results of operations.", "sentB": "However, the Company closely reviews its methods of operations and seeks to adopt strategies responsive to changing economic and political conditions.", "type": 1, "words": ["<tag1>", "However,", "the", "loss", "of", "one", "or", "more", "of", "these", "distributors,", "together", "with", "a", "delay", "or", "inability", "to", "secure", "an", "alternative", "distribution", "source", "for", "end", "users,", "could", "have", "a", "material", "negative", "impact", "on", "our", "revenue,", "business,", "financial", "condition", "and", "results", "of", "operations.", "<tag2>", "However,", "the", "Company", "closely", "reviews", "its", "methods", "of", "operations", "and", "seeks", "to", "adopt", "strategies", "responsive", "to", "changing", "economic", "and", "political", "conditions.", "<tag3>"], "wordsA": ["However,", "the", "loss", "of", "one", "or", "more", "of", "these", "distributors,", "together", "with", "a", "delay", "or", "inability", "to", "secure", "an", "alternative", "distribution", "source", "for", "end", "users,", "could", "have", "a", "material", "negative", "impact", "on", "our", "revenue,", "business,", "financial", "condition", "and", "results", "of", "operations."], "wordsB": ["However,", "the", "Company", "closely", "reviews", "its", "methods", "of", "operations", "and", "seeks", "to", "adopt", "strategies", "responsive", "to", "changing", "economic", "and", "political", "conditions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_15_item1_p68_s0", "idA": "3116_14_item1_p60_s0", "sentA": "Seasonality and other Cyclical Sales Fluctuations .", "sentB": "The Company s worldwide business is subject to risks of currency fluctuations, governmental actions and other governmental proceedings abroad.", "type": 1, "words": ["<tag1>", "Seasonality", "and", "other", "Cyclical", "Sales", "Fluctuations", ".", "<tag2>", "The", "Company", "s", "worldwide", "business", "is", "subject", "to", "risks", "of", "currency", "fluctuations,", "governmental", "actions", "and", "other", "governmental", "proceedings", "abroad.", "<tag3>"], "wordsA": ["Seasonality", "and", "other", "Cyclical", "Sales", "Fluctuations", "."], "wordsB": ["The", "Company", "s", "worldwide", "business", "is", "subject", "to", "risks", "of", "currency", "fluctuations,", "governmental", "actions", "and", "other", "governmental", "proceedings", "abroad."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_15_item1_p15_s2", "idA": "3116_14_item1_p60_s1", "sentA": "Most of our business segments do not experience significant seasonality.", "sentB": "Below is a summary of our recent strategic acquisitions of companies and businesses.", "type": 1, "words": ["<tag1>", "Most", "of", "our", "business", "segments", "do", "not", "experience", "significant", "seasonality.", "<tag2>", "Below", "is", "a", "summary", "of", "our", "recent", "strategic", "acquisitions", "of", "companies", "and", "businesses.", "<tag3>"], "wordsA": ["Most", "of", "our", "business", "segments", "do", "not", "experience", "significant", "seasonality."], "wordsB": ["Below", "is", "a", "summary", "of", "our", "recent", "strategic", "acquisitions", "of", "companies", "and", "businesses."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_16_item1_p9_s0", "idA": "3116_15_item1_p0_s1", "sentA": "We specialize in difficult-to-manufacture sterile and non-sterile dosage forms including: ophthalmics, injectables, oral liquids, otics, topicals, inhalants, and nasal sprays.", "sentB": "Research and development expertise in alternative dosage forms.", "type": 1, "words": ["<tag1>", "We", "specialize", "in", "difficult-to-manufacture", "sterile", "and", "non-sterile", "dosage", "forms", "including:", "ophthalmics,", "injectables,", "oral", "liquids,", "otics,", "topicals,", "inhalants,", "and", "nasal", "sprays.", "<tag2>", "Research", "and", "development", "expertise", "in", "alternative", "dosage", "forms.", "<tag3>"], "wordsA": ["We", "specialize", "in", "difficult-to-manufacture", "sterile", "and", "non-sterile", "dosage", "forms", "including:", "ophthalmics,", "injectables,", "oral", "liquids,", "otics,", "topicals,", "inhalants,", "and", "nasal", "sprays."], "wordsB": ["Research", "and", "development", "expertise", "in", "alternative", "dosage", "forms."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_16_item1_p17_s2", "idA": "3116_15_item1_p10_s4", "sentA": "We also utilize outside vendors for portions of R D projects to take advantage of external capabilities and cost-efficiencies.", "sentB": "We also market select oral solid dose formulations.", "type": 1, "words": ["<tag1>", "We", "also", "utilize", "outside", "vendors", "for", "portions", "of", "R", "D", "projects", "to", "take", "advantage", "of", "external", "capabilities", "and", "cost-efficiencies.", "<tag2>", "We", "also", "market", "select", "oral", "solid", "dose", "formulations.", "<tag3>"], "wordsA": ["We", "also", "utilize", "outside", "vendors", "for", "portions", "of", "R", "D", "projects", "to", "take", "advantage", "of", "external", "capabilities", "and", "cost-efficiencies."], "wordsB": ["We", "also", "market", "select", "oral", "solid", "dose", "formulations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_16_item1_p9_s1", "idA": "3116_15_item1_p11_s0", "sentA": "We strategically partner with drug development and manufacturing companies throughout the world for the development of drug products that we believe will be complementary to our existing product offerings, but for which we may lack the expertise to develop or the capability, capacity, or cost-efficiencies to manufacture.", "sentB": "Our R D efforts are primarily focused on the development of multisource generic products that are in dosage forms other than oral solid dose.", "type": 1, "words": ["<tag1>", "We", "strategically", "partner", "with", "drug", "development", "and", "manufacturing", "companies", "throughout", "the", "world", "for", "the", "development", "of", "drug", "products", "that", "we", "believe", "will", "be", "complementary", "to", "our", "existing", "product", "offerings,", "but", "for", "which", "we", "may", "lack", "the", "expertise", "to", "develop", "or", "the", "capability,", "capacity,", "or", "cost-efficiencies", "to", "manufacture.", "<tag2>", "Our", "R", "D", "efforts", "are", "primarily", "focused", "on", "the", "development", "of", "multisource", "generic", "products", "that", "are", "in", "dosage", "forms", "other", "than", "oral", "solid", "dose.", "<tag3>"], "wordsA": ["We", "strategically", "partner", "with", "drug", "development", "and", "manufacturing", "companies", "throughout", "the", "world", "for", "the", "development", "of", "drug", "products", "that", "we", "believe", "will", "be", "complementary", "to", "our", "existing", "product", "offerings,", "but", "for", "which", "we", "may", "lack", "the", "expertise", "to", "develop", "or", "the", "capability,", "capacity,", "or", "cost-efficiencies", "to", "manufacture."], "wordsB": ["Our", "R", "D", "efforts", "are", "primarily", "focused", "on", "the", "development", "of", "multisource", "generic", "products", "that", "are", "in", "dosage", "forms", "other", "than", "oral", "solid", "dose."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_16_item1_p115_s0", "idA": "3116_15_item1_p11_s1", "sentA": "We may owe payments to these partners from time to time based on their achievement of milestones, up to and including launch of the product.", "sentB": "The Federal Physician Payments Sunshine Act mandates annual reporting of various types of payments to physicians and teaching hospitals.", "type": 1, "words": ["<tag1>", "We", "may", "owe", "payments", "to", "these", "partners", "from", "time", "to", "time", "based", "on", "their", "achievement", "of", "milestones,", "up", "to", "and", "including", "launch", "of", "the", "product.", "<tag2>", "The", "Federal", "Physician", "Payments", "Sunshine", "Act", "mandates", "annual", "reporting", "of", "various", "types", "of", "payments", "to", "physicians", "and", "teaching", "hospitals.", "<tag3>"], "wordsA": ["We", "may", "owe", "payments", "to", "these", "partners", "from", "time", "to", "time", "based", "on", "their", "achievement", "of", "milestones,", "up", "to", "and", "including", "launch", "of", "the", "product."], "wordsB": ["The", "Federal", "Physician", "Payments", "Sunshine", "Act", "mandates", "annual", "reporting", "of", "various", "types", "of", "payments", "to", "physicians", "and", "teaching", "hospitals."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_16_item1_p66_s0", "idA": "3116_15_item1_p11_s2", "sentA": "Our development partner is typically responsible for manufacturing or sourcing of the finished product, and receives a royalty or a profit split from the sales of the product.", "sentB": "We acquired Nembutal Sodium Solution from the Lundbeck Acquisition.", "type": 1, "words": ["<tag1>", "Our", "development", "partner", "is", "typically", "responsible", "for", "manufacturing", "or", "sourcing", "of", "the", "finished", "product,", "and", "receives", "a", "royalty", "or", "a", "profit", "split", "from", "the", "sales", "of", "the", "product.", "<tag2>", "We", "acquired", "Nembutal", "Sodium", "Solution", "from", "the", "Lundbeck", "Acquisition.", "<tag3>"], "wordsA": ["Our", "development", "partner", "is", "typically", "responsible", "for", "manufacturing", "or", "sourcing", "of", "the", "finished", "product,", "and", "receives", "a", "royalty", "or", "a", "profit", "split", "from", "the", "sales", "of", "the", "product."], "wordsB": ["We", "acquired", "Nembutal", "Sodium", "Solution", "from", "the", "Lundbeck", "Acquisition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_16_item1_p68_s0", "idA": "3116_15_item1_p13_s0", "sentA": "We received 14 Abbreviated New Drug Application ( ANDA ) product approvals, one New Drug Application ( NDA ) product approval and two tentative ANDA approvals from the FDA in 2014; 2 approvals and 1 tentative approval in 2013 and 5 approvals in 2012.", "sentB": "Under a license from another manufacturer, we began marketing progesterone capsules in 100 mg and 200 mg strengths in 2012.", "type": 1, "words": ["<tag1>", "We", "received", "14", "Abbreviated", "New", "Drug", "Application", "(", "ANDA", ")", "product", "approvals,", "one", "New", "Drug", "Application", "(", "NDA", ")", "product", "approval", "and", "two", "tentative", "ANDA", "approvals", "from", "the", "FDA", "in", "2014;", "2", "approvals", "and", "1", "tentative", "approval", "in", "2013", "and", "5", "approvals", "in", "2012.", "<tag2>", "Under", "a", "license", "from", "another", "manufacturer,", "we", "began", "marketing", "progesterone", "capsules", "in", "100", "mg", "and", "200", "mg", "strengths", "in", "2012.", "<tag3>"], "wordsA": ["We", "received", "14", "Abbreviated", "New", "Drug", "Application", "(", "ANDA", ")", "product", "approvals,", "one", "New", "Drug", "Application", "(", "NDA", ")", "product", "approval", "and", "two", "tentative", "ANDA", "approvals", "from", "the", "FDA", "in", "2014;", "2", "approvals", "and", "1", "tentative", "approval", "in", "2013", "and", "5", "approvals", "in", "2012."], "wordsB": ["Under", "a", "license", "from", "another", "manufacturer,", "we", "began", "marketing", "progesterone", "capsules", "in", "100", "mg", "and", "200", "mg", "strengths", "in", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_16_item1_p9_s3", "idA": "3116_15_item1_p14_s0", "sentA": "See Government Regulation and Item 1A. Risk Factors Our growth depends on our ability to timely develop and successfully market new pharmaceutical products.", "sentB": "These products typically have fewer competitors in mature markets, are more difficult to develop and manufacture and can carry higher profitability over time than oral solid dose products.", "type": 1, "words": ["<tag1>", "See", "Government", "Regulation", "and", "Item", "1A.", "Risk", "Factors", "Our", "growth", "depends", "on", "our", "ability", "to", "timely", "develop", "and", "successfully", "market", "new", "pharmaceutical", "products.", "<tag2>", "These", "products", "typically", "have", "fewer", "competitors", "in", "mature", "markets,", "are", "more", "difficult", "to", "develop", "and", "manufacture", "and", "can", "carry", "higher", "profitability", "over", "time", "than", "oral", "solid", "dose", "products.", "<tag3>"], "wordsA": ["See", "Government", "Regulation", "and", "Item", "1A.", "Risk", "Factors", "Our", "growth", "depends", "on", "our", "ability", "to", "timely", "develop", "and", "successfully", "market", "new", "pharmaceutical", "products."], "wordsB": ["These", "products", "typically", "have", "fewer", "competitors", "in", "mature", "markets,", "are", "more", "difficult", "to", "develop", "and", "manufacture", "and", "can", "carry", "higher", "profitability", "over", "time", "than", "oral", "solid", "dose", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_16_item1_p16_s0", "idA": "3116_15_item1_p15_s0", "sentA": "We actively seek to expand and enhance our business through strategic acquisitions.", "sentB": "Our senior management team has a demonstrated track record of building and operating high-growth healthcare and pharmaceutical companies through product development, in-licensing and acquisitions.", "type": 1, "words": ["<tag1>", "We", "actively", "seek", "to", "expand", "and", "enhance", "our", "business", "through", "strategic", "acquisitions.", "<tag2>", "Our", "senior", "management", "team", "has", "a", "demonstrated", "track", "record", "of", "building", "and", "operating", "high-growth", "healthcare", "and", "pharmaceutical", "companies", "through", "product", "development,", "in-licensing", "and", "acquisitions.", "<tag3>"], "wordsA": ["We", "actively", "seek", "to", "expand", "and", "enhance", "our", "business", "through", "strategic", "acquisitions."], "wordsB": ["Our", "senior", "management", "team", "has", "a", "demonstrated", "track", "record", "of", "building", "and", "operating", "high-growth", "healthcare", "and", "pharmaceutical", "companies", "through", "product", "development,", "in-licensing", "and", "acquisitions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_16_item1_p77_s1", "idA": "3116_15_item1_p1_s2", "sentA": "We operate pharmaceutical manufacturing facilities in Decatur, Illinois; Somerset, New Jersey; Amityville, New York; and Paonta Sahib, Himachal Pradesh, India, as well as a central distribution warehouse in Gurnee, Illinois, and an additional warehousing facility in Amityville, New York.", "sentB": "Additionally, potential generic entrants with equivalent products referencing our branded products present an additional competitive threat.", "type": 1, "words": ["<tag1>", "We", "operate", "pharmaceutical", "manufacturing", "facilities", "in", "Decatur,", "Illinois;", "Somerset,", "New", "Jersey;", "Amityville,", "New", "York;", "and", "Paonta", "Sahib,", "Himachal", "Pradesh,", "India,", "as", "well", "as", "a", "central", "distribution", "warehouse", "in", "Gurnee,", "Illinois,", "and", "an", "additional", "warehousing", "facility", "in", "Amityville,", "New", "York.", "<tag2>", "Additionally,", "potential", "generic", "entrants", "with", "equivalent", "products", "referencing", "our", "branded", "products", "present", "an", "additional", "competitive", "threat.", "<tag3>"], "wordsA": ["We", "operate", "pharmaceutical", "manufacturing", "facilities", "in", "Decatur,", "Illinois;", "Somerset,", "New", "Jersey;", "Amityville,", "New", "York;", "and", "Paonta", "Sahib,", "Himachal", "Pradesh,", "India,", "as", "well", "as", "a", "central", "distribution", "warehouse", "in", "Gurnee,", "Illinois,", "and", "an", "additional", "warehousing", "facility", "in", "Amityville,", "New", "York."], "wordsB": ["Additionally,", "potential", "generic", "entrants", "with", "equivalent", "products", "referencing", "our", "branded", "products", "present", "an", "additional", "competitive", "threat."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_16_item1_p65_s0", "idA": "3116_15_item1_p21_s0", "sentA": "The VersaPharm Acquisition complements and expands the Company s product portfolio by diversifying its offering to niche dermatology markets.", "sentB": "We acquired Myorisan (isotretinoin capsules, USP) in 10 mg, 20 mg and 40 mg strengths through the VersaPharm Acquisition.", "type": 1, "words": ["<tag1>", "The", "VersaPharm", "Acquisition", "complements", "and", "expands", "the", "Company", "s", "product", "portfolio", "by", "diversifying", "its", "offering", "to", "niche", "dermatology", "markets.", "<tag2>", "We", "acquired", "Myorisan", "(isotretinoin", "capsules,", "USP)", "in", "10", "mg,", "20", "mg", "and", "40", "mg", "strengths", "through", "the", "VersaPharm", "Acquisition.", "<tag3>"], "wordsA": ["The", "VersaPharm", "Acquisition", "complements", "and", "expands", "the", "Company", "s", "product", "portfolio", "by", "diversifying", "its", "offering", "to", "niche", "dermatology", "markets."], "wordsB": ["We", "acquired", "Myorisan", "(isotretinoin", "capsules,", "USP)", "in", "10", "mg,", "20", "mg", "and", "40", "mg", "strengths", "through", "the", "VersaPharm", "Acquisition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_16_item1_p19_s2", "idA": "3116_15_item1_p26_s0", "sentA": "Hi-Tech is a specialty pharmaceutical company which develops, manufactures and markets generic and branded prescription and OTC products.", "sentB": "We also market several specialty OTC products including; Zostrix , Sinus Buster , MagOx , Maginex , Multi-betic , Diabetic Tussin and Dia-Derm .", "type": 1, "words": ["<tag1>", "Hi-Tech", "is", "a", "specialty", "pharmaceutical", "company", "which", "develops,", "manufactures", "and", "markets", "generic", "and", "branded", "prescription", "and", "OTC", "products.", "<tag2>", "We", "also", "market", "several", "specialty", "OTC", "products", "including;", "Zostrix", ",", "Sinus", "Buster", ",", "MagOx", ",", "Maginex", ",", "Multi-betic", ",", "Diabetic", "Tussin", "and", "Dia-Derm", ".", "<tag3>"], "wordsA": ["Hi-Tech", "is", "a", "specialty", "pharmaceutical", "company", "which", "develops,", "manufactures", "and", "markets", "generic", "and", "branded", "prescription", "and", "OTC", "products."], "wordsB": ["We", "also", "market", "several", "specialty", "OTC", "products", "including;", "Zostrix", ",", "Sinus", "Buster", ",", "MagOx", ",", "Maginex", ",", "Multi-betic", ",", "Diabetic", "Tussin", "and", "Dia-Derm", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_16_item1_p5_s1", "idA": "3116_15_item1_p26_s1", "sentA": "Hi-Tech specializes in difficult to manufacture liquid and semi-solid dosage forms and produces and markets a range of oral solutions and suspensions, as well as topical ointments and creams, nasal sprays, otics, sterile ophthalmics and sterile ointment and gel products.", "sentB": "Through an efficient operational model, we strive to maximize shareholder value by quickly adapting to market conditions, patient demands and customer needs.", "type": 1, "words": ["<tag1>", "Hi-Tech", "specializes", "in", "difficult", "to", "manufacture", "liquid", "and", "semi-solid", "dosage", "forms", "and", "produces", "and", "markets", "a", "range", "of", "oral", "solutions", "and", "suspensions,", "as", "well", "as", "topical", "ointments", "and", "creams,", "nasal", "sprays,", "otics,", "sterile", "ophthalmics", "and", "sterile", "ointment", "and", "gel", "products.", "<tag2>", "Through", "an", "efficient", "operational", "model,", "we", "strive", "to", "maximize", "shareholder", "value", "by", "quickly", "adapting", "to", "market", "conditions,", "patient", "demands", "and", "customer", "needs.", "<tag3>"], "wordsA": ["Hi-Tech", "specializes", "in", "difficult", "to", "manufacture", "liquid", "and", "semi-solid", "dosage", "forms", "and", "produces", "and", "markets", "a", "range", "of", "oral", "solutions", "and", "suspensions,", "as", "well", "as", "topical", "ointments", "and", "creams,", "nasal", "sprays,", "otics,", "sterile", "ophthalmics", "and", "sterile", "ointment", "and", "gel", "products."], "wordsB": ["Through", "an", "efficient", "operational", "model,", "we", "strive", "to", "maximize", "shareholder", "value", "by", "quickly", "adapting", "to", "market", "conditions,", "patient", "demands", "and", "customer", "needs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_16_item1_p60_s0", "idA": "3116_15_item1_p26_s1", "sentA": "Hi-Tech specializes in difficult to manufacture liquid and semi-solid dosage forms and produces and markets a range of oral solutions and suspensions, as well as topical ointments and creams, nasal sprays, otics, sterile ophthalmics and sterile ointment and gel products.", "sentB": "We began marketing our Dehydrated Alcohol Injection, USP in 5 mL single-dose vials in 1997.", "type": 1, "words": ["<tag1>", "Hi-Tech", "specializes", "in", "difficult", "to", "manufacture", "liquid", "and", "semi-solid", "dosage", "forms", "and", "produces", "and", "markets", "a", "range", "of", "oral", "solutions", "and", "suspensions,", "as", "well", "as", "topical", "ointments", "and", "creams,", "nasal", "sprays,", "otics,", "sterile", "ophthalmics", "and", "sterile", "ointment", "and", "gel", "products.", "<tag2>", "We", "began", "marketing", "our", "Dehydrated", "Alcohol", "Injection,", "USP", "in", "5", "mL", "single-dose", "vials", "in", "1997.", "<tag3>"], "wordsA": ["Hi-Tech", "specializes", "in", "difficult", "to", "manufacture", "liquid", "and", "semi-solid", "dosage", "forms", "and", "produces", "and", "markets", "a", "range", "of", "oral", "solutions", "and", "suspensions,", "as", "well", "as", "topical", "ointments", "and", "creams,", "nasal", "sprays,", "otics,", "sterile", "ophthalmics", "and", "sterile", "ointment", "and", "gel", "products."], "wordsB": ["We", "began", "marketing", "our", "Dehydrated", "Alcohol", "Injection,", "USP", "in", "5", "mL", "single-dose", "vials", "in", "1997."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_16_item1_p61_s0", "idA": "3116_15_item1_p26_s1", "sentA": "Hi-Tech specializes in difficult to manufacture liquid and semi-solid dosage forms and produces and markets a range of oral solutions and suspensions, as well as topical ointments and creams, nasal sprays, otics, sterile ophthalmics and sterile ointment and gel products.", "sentB": "We began marketing Ephedrine Sulfate Injection, USP 50 mg/mL in 1 mL single-dose ampules in 1997.", "type": 1, "words": ["<tag1>", "Hi-Tech", "specializes", "in", "difficult", "to", "manufacture", "liquid", "and", "semi-solid", "dosage", "forms", "and", "produces", "and", "markets", "a", "range", "of", "oral", "solutions", "and", "suspensions,", "as", "well", "as", "topical", "ointments", "and", "creams,", "nasal", "sprays,", "otics,", "sterile", "ophthalmics", "and", "sterile", "ointment", "and", "gel", "products.", "<tag2>", "We", "began", "marketing", "Ephedrine", "Sulfate", "Injection,", "USP", "50", "mg/mL", "in", "1", "mL", "single-dose", "ampules", "in", "1997.", "<tag3>"], "wordsA": ["Hi-Tech", "specializes", "in", "difficult", "to", "manufacture", "liquid", "and", "semi-solid", "dosage", "forms", "and", "produces", "and", "markets", "a", "range", "of", "oral", "solutions", "and", "suspensions,", "as", "well", "as", "topical", "ointments", "and", "creams,", "nasal", "sprays,", "otics,", "sterile", "ophthalmics", "and", "sterile", "ointment", "and", "gel", "products."], "wordsB": ["We", "began", "marketing", "Ephedrine", "Sulfate", "Injection,", "USP", "50", "mg/mL", "in", "1", "mL", "single-dose", "ampules", "in", "1997."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_16_item1_p64_s0", "idA": "3116_15_item1_p26_s1", "sentA": "Hi-Tech specializes in difficult to manufacture liquid and semi-solid dosage forms and produces and markets a range of oral solutions and suspensions, as well as topical ointments and creams, nasal sprays, otics, sterile ophthalmics and sterile ointment and gel products.", "sentB": "We began marketing Methylene Blue Injection, USP, 10 mg/mL in 1 mL and 10 mL vials in 2009.", "type": 1, "words": ["<tag1>", "Hi-Tech", "specializes", "in", "difficult", "to", "manufacture", "liquid", "and", "semi-solid", "dosage", "forms", "and", "produces", "and", "markets", "a", "range", "of", "oral", "solutions", "and", "suspensions,", "as", "well", "as", "topical", "ointments", "and", "creams,", "nasal", "sprays,", "otics,", "sterile", "ophthalmics", "and", "sterile", "ointment", "and", "gel", "products.", "<tag2>", "We", "began", "marketing", "Methylene", "Blue", "Injection,", "USP,", "10", "mg/mL", "in", "1", "mL", "and", "10", "mL", "vials", "in", "2009.", "<tag3>"], "wordsA": ["Hi-Tech", "specializes", "in", "difficult", "to", "manufacture", "liquid", "and", "semi-solid", "dosage", "forms", "and", "produces", "and", "markets", "a", "range", "of", "oral", "solutions", "and", "suspensions,", "as", "well", "as", "topical", "ointments", "and", "creams,", "nasal", "sprays,", "otics,", "sterile", "ophthalmics", "and", "sterile", "ointment", "and", "gel", "products."], "wordsB": ["We", "began", "marketing", "Methylene", "Blue", "Injection,", "USP,", "10", "mg/mL", "in", "1", "mL", "and", "10", "mL", "vials", "in", "2009."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_16_item1_p2_s0", "idA": "3116_15_item1_p2_s2", "sentA": "For information regarding revenues and gross profit for each of our segments, see Item 7 Results of Operations and Note 12 Segment Information in the Notes to our Consolidated Financial Statements.", "sentB": "For further detail concerning our reportable segments please see Part II, Item 8 - Note 14 Segment Information.", "type": 1, "words": ["<tag1>", "For", "information", "regarding", "revenues", "and", "gross", "profit", "for", "each", "of", "our", "segments,", "see", "Item", "7", "Results", "of", "Operations", "and", "Note", "12", "Segment", "Information", "in", "the", "Notes", "to", "our", "Consolidated", "Financial", "Statements.", "<tag2>", "For", "further", "detail", "concerning", "our", "reportable", "segments", "please", "see", "Part", "II,", "Item", "8", "-", "Note", "14", "Segment", "Information.", "<tag3>"], "wordsA": ["For", "information", "regarding", "revenues", "and", "gross", "profit", "for", "each", "of", "our", "segments,", "see", "Item", "7", "Results", "of", "Operations", "and", "Note", "12", "Segment", "Information", "in", "the", "Notes", "to", "our", "Consolidated", "Financial", "Statements."], "wordsB": ["For", "further", "detail", "concerning", "our", "reportable", "segments", "please", "see", "Part", "II,", "Item", "8", "-", "Note", "14", "Segment", "Information."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_16_item1_p63_s1", "idA": "3116_15_item1_p31_s0", "sentA": "In addition to our acquisitions of companies, we also maintain a business development program that identifies potential product acquisition or product licensing opportunities.", "sentB": "Beyond Lidocaine Ointment, we also market other Lidocaine-containing products including Lidocaine Hydrochloride Jelly USP 2% and Lidocaine Hydrochloride Oral Topical Solution USP, 2%.", "type": 1, "words": ["<tag1>", "In", "addition", "to", "our", "acquisitions", "of", "companies,", "we", "also", "maintain", "a", "business", "development", "program", "that", "identifies", "potential", "product", "acquisition", "or", "product", "licensing", "opportunities.", "<tag2>", "Beyond", "Lidocaine", "Ointment,", "we", "also", "market", "other", "Lidocaine-containing", "products", "including", "Lidocaine", "Hydrochloride", "Jelly", "USP", "2%", "and", "Lidocaine", "Hydrochloride", "Oral", "Topical", "Solution", "USP,", "2%.", "<tag3>"], "wordsA": ["In", "addition", "to", "our", "acquisitions", "of", "companies,", "we", "also", "maintain", "a", "business", "development", "program", "that", "identifies", "potential", "product", "acquisition", "or", "product", "licensing", "opportunities."], "wordsB": ["Beyond", "Lidocaine", "Ointment,", "we", "also", "market", "other", "Lidocaine-containing", "products", "including", "Lidocaine", "Hydrochloride", "Jelly", "USP", "2%", "and", "Lidocaine", "Hydrochloride", "Oral", "Topical", "Solution", "USP,", "2%."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_16_item1_p69_s0", "idA": "3116_15_item1_p32_s1", "sentA": "The Company acquired the products for $16.1 million, funded through available cash paid at closing, and a contingent payment of $2.0 million, which becomes payable upon FDA approval of a supplement related to one of the acquired products.", "sentB": "Most of the products discussed above have several generic equivalent competitors.", "type": 1, "words": ["<tag1>", "The", "Company", "acquired", "the", "products", "for", "$16.1", "million,", "funded", "through", "available", "cash", "paid", "at", "closing,", "and", "a", "contingent", "payment", "of", "$2.0", "million,", "which", "becomes", "payable", "upon", "FDA", "approval", "of", "a", "supplement", "related", "to", "one", "of", "the", "acquired", "products.", "<tag2>", "Most", "of", "the", "products", "discussed", "above", "have", "several", "generic", "equivalent", "competitors.", "<tag3>"], "wordsA": ["The", "Company", "acquired", "the", "products", "for", "$16.1", "million,", "funded", "through", "available", "cash", "paid", "at", "closing,", "and", "a", "contingent", "payment", "of", "$2.0", "million,", "which", "becomes", "payable", "upon", "FDA", "approval", "of", "a", "supplement", "related", "to", "one", "of", "the", "acquired", "products."], "wordsB": ["Most", "of", "the", "products", "discussed", "above", "have", "several", "generic", "equivalent", "competitors."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_16_item1_p29_s2", "idA": "3116_15_item1_p35_s0", "sentA": "On April 1, 2014, the Company acquired from Merck, Sharp and Dohme Corp. ( Merck ) the U.S. NDA rights to Zioptan , a prescription ophthalmic eye drop indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension, from Merck, Sharp and Dohme Corp. ( Merck ).", "sentB": "On April 1, 2016 the name of Excelvision AG was changed to Akorn AG.", "type": 1, "words": ["<tag1>", "On", "April", "1,", "2014,", "the", "Company", "acquired", "from", "Merck,", "Sharp", "and", "Dohme", "Corp.", "(", "Merck", ")", "the", "U.S.", "NDA", "rights", "to", "Zioptan", ",", "a", "prescription", "ophthalmic", "eye", "drop", "indicated", "for", "reducing", "elevated", "intraocular", "pressure", "in", "patients", "with", "open-angle", "glaucoma", "or", "ocular", "hypertension,", "from", "Merck,", "Sharp", "and", "Dohme", "Corp.", "(", "Merck", ").", "<tag2>", "On", "April", "1,", "2016", "the", "name", "of", "Excelvision", "AG", "was", "changed", "to", "Akorn", "AG.", "<tag3>"], "wordsA": ["On", "April", "1,", "2014,", "the", "Company", "acquired", "from", "Merck,", "Sharp", "and", "Dohme", "Corp.", "(", "Merck", ")", "the", "U.S.", "NDA", "rights", "to", "Zioptan", ",", "a", "prescription", "ophthalmic", "eye", "drop", "indicated", "for", "reducing", "elevated", "intraocular", "pressure", "in", "patients", "with", "open-angle", "glaucoma", "or", "ocular", "hypertension,", "from", "Merck,", "Sharp", "and", "Dohme", "Corp.", "(", "Merck", ")."], "wordsB": ["On", "April", "1,", "2016", "the", "name", "of", "Excelvision", "AG", "was", "changed", "to", "Akorn", "AG."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_16_item1_p114_s1", "idA": "3116_15_item1_p36_s0", "sentA": "In connection with the acquisition, the Company entered into a master supply agreement with Merck whereby Merck will continue manufacturing Zioptan for a transitional period.", "sentB": "Also, false statement provisions within HIPAA prohibits knowingly and willingly falsifying, concealing or covering up a material fact or making any materially false, fictitious or fraudulent statement in connection with the delivery of or payment for healthcare benefits, items or services.", "type": 1, "words": ["<tag1>", "In", "connection", "with", "the", "acquisition,", "the", "Company", "entered", "into", "a", "master", "supply", "agreement", "with", "Merck", "whereby", "Merck", "will", "continue", "manufacturing", "Zioptan", "for", "a", "transitional", "period.", "<tag2>", "Also,", "false", "statement", "provisions", "within", "HIPAA", "prohibits", "knowingly", "and", "willingly", "falsifying,", "concealing", "or", "covering", "up", "a", "material", "fact", "or", "making", "any", "materially", "false,", "fictitious", "or", "fraudulent", "statement", "in", "connection", "with", "the", "delivery", "of", "or", "payment", "for", "healthcare", "benefits,", "items", "or", "services.", "<tag3>"], "wordsA": ["In", "connection", "with", "the", "acquisition,", "the", "Company", "entered", "into", "a", "master", "supply", "agreement", "with", "Merck", "whereby", "Merck", "will", "continue", "manufacturing", "Zioptan", "for", "a", "transitional", "period."], "wordsB": ["Also,", "false", "statement", "provisions", "within", "HIPAA", "prohibits", "knowingly", "and", "willingly", "falsifying,", "concealing", "or", "covering", "up", "a", "material", "fact", "or", "making", "any", "materially", "false,", "fictitious", "or", "fraudulent", "statement", "in", "connection", "with", "the", "delivery", "of", "or", "payment", "for", "healthcare", "benefits,", "items", "or", "services."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_16_item1_p114_s0", "idA": "3116_15_item1_p37_s2", "sentA": "The total consideration will be equal to 1.5 times the Company s net sales of Betimol in the first year following the acquisition.", "sentB": "Fraud provisions in the Health Insurance Portability and Accountability Act ( HIPAA ) of 1996 prohibits knowingly and willingly executing a scheme to defraud any healthcare benefit program, including those of private third-party payers.", "type": 1, "words": ["<tag1>", "The", "total", "consideration", "will", "be", "equal", "to", "1.5", "times", "the", "Company", "s", "net", "sales", "of", "Betimol", "in", "the", "first", "year", "following", "the", "acquisition.", "<tag2>", "Fraud", "provisions", "in", "the", "Health", "Insurance", "Portability", "and", "Accountability", "Act", "(", "HIPAA", ")", "of", "1996", "prohibits", "knowingly", "and", "willingly", "executing", "a", "scheme", "to", "defraud", "any", "healthcare", "benefit", "program,", "including", "those", "of", "private", "third-party", "payers.", "<tag3>"], "wordsA": ["The", "total", "consideration", "will", "be", "equal", "to", "1.5", "times", "the", "Company", "s", "net", "sales", "of", "Betimol", "in", "the", "first", "year", "following", "the", "acquisition."], "wordsB": ["Fraud", "provisions", "in", "the", "Health", "Insurance", "Portability", "and", "Accountability", "Act", "(", "HIPAA", ")", "of", "1996", "prohibits", "knowingly", "and", "willingly", "executing", "a", "scheme", "to", "defraud", "any", "healthcare", "benefit", "program,", "including", "those", "of", "private", "third-party", "payers."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_16_item1_p113_s1", "idA": "3116_15_item1_p37_s4", "sentA": "There is also a provision for a $2.0 million increase to the total consideration should net sales of Betimol exceed a sizable threshold in any one of the first five years following the acquisition.", "sentB": "The qui tam provisions of the False Claims Act allow a private individual to bring civil actions on behalf of the federal government alleging that the defendant has submitted or caused the submission of a false claim to the federal government, and to share in any monetary recovery.", "type": 1, "words": ["<tag1>", "There", "is", "also", "a", "provision", "for", "a", "$2.0", "million", "increase", "to", "the", "total", "consideration", "should", "net", "sales", "of", "Betimol", "exceed", "a", "sizable", "threshold", "in", "any", "one", "of", "the", "first", "five", "years", "following", "the", "acquisition.", "<tag2>", "The", "qui", "tam", "provisions", "of", "the", "False", "Claims", "Act", "allow", "a", "private", "individual", "to", "bring", "civil", "actions", "on", "behalf", "of", "the", "federal", "government", "alleging", "that", "the", "defendant", "has", "submitted", "or", "caused", "the", "submission", "of", "a", "false", "claim", "to", "the", "federal", "government,", "and", "to", "share", "in", "any", "monetary", "recovery.", "<tag3>"], "wordsA": ["There", "is", "also", "a", "provision", "for", "a", "$2.0", "million", "increase", "to", "the", "total", "consideration", "should", "net", "sales", "of", "Betimol", "exceed", "a", "sizable", "threshold", "in", "any", "one", "of", "the", "first", "five", "years", "following", "the", "acquisition."], "wordsB": ["The", "qui", "tam", "provisions", "of", "the", "False", "Claims", "Act", "allow", "a", "private", "individual", "to", "bring", "civil", "actions", "on", "behalf", "of", "the", "federal", "government", "alleging", "that", "the", "defendant", "has", "submitted", "or", "caused", "the", "submission", "of", "a", "false", "claim", "to", "the", "federal", "government,", "and", "to", "share", "in", "any", "monetary", "recovery."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_16_item1_p113_s2", "idA": "3116_15_item1_p43_s1", "sentA": "Through our acquisitions, we have increased the number and importance of trademarks related to our products and product lines.", "sentB": "In recent years, the number or suits brought by private individuals has increased dramatically.", "type": 1, "words": ["<tag1>", "Through", "our", "acquisitions,", "we", "have", "increased", "the", "number", "and", "importance", "of", "trademarks", "related", "to", "our", "products", "and", "product", "lines.", "<tag2>", "In", "recent", "years,", "the", "number", "or", "suits", "brought", "by", "private", "individuals", "has", "increased", "dramatically.", "<tag3>"], "wordsA": ["Through", "our", "acquisitions,", "we", "have", "increased", "the", "number", "and", "importance", "of", "trademarks", "related", "to", "our", "products", "and", "product", "lines."], "wordsB": ["In", "recent", "years,", "the", "number", "or", "suits", "brought", "by", "private", "individuals", "has", "increased", "dramatically."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_16_item1_p6_s0", "idA": "3116_15_item1_p46_s2", "sentA": "We believe we have good relations with our employees.", "sentB": "We believe we can generate growth and maintain attractive margins through: new product launches resulting from research and development successes, improving execution on our core strengths, optimizing our cash flow and leveraging our customer relationships and market leadership.", "type": 1, "words": ["<tag1>", "We", "believe", "we", "have", "good", "relations", "with", "our", "employees.", "<tag2>", "We", "believe", "we", "can", "generate", "growth", "and", "maintain", "attractive", "margins", "through:", "new", "product", "launches", "resulting", "from", "research", "and", "development", "successes,", "improving", "execution", "on", "our", "core", "strengths,", "optimizing", "our", "cash", "flow", "and", "leveraging", "our", "customer", "relationships", "and", "market", "leadership.", "<tag3>"], "wordsA": ["We", "believe", "we", "have", "good", "relations", "with", "our", "employees."], "wordsB": ["We", "believe", "we", "can", "generate", "growth", "and", "maintain", "attractive", "margins", "through:", "new", "product", "launches", "resulting", "from", "research", "and", "development", "successes,", "improving", "execution", "on", "our", "core", "strengths,", "optimizing", "our", "cash", "flow", "and", "leveraging", "our", "customer", "relationships", "and", "market", "leadership."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_16_item1_p113_s0", "idA": "3116_15_item1_p46_s3", "sentA": "None of our employees are represented by a collective bargaining agreement.", "sentB": "The civil False Claims Act imposes liability on any person or entity that, among other things, knowingly presents, or causes to be presented, a false or fraudulent claim for payment by a federal healthcare program.", "type": 1, "words": ["<tag1>", "None", "of", "our", "employees", "are", "represented", "by", "a", "collective", "bargaining", "agreement.", "<tag2>", "The", "civil", "False", "Claims", "Act", "imposes", "liability", "on", "any", "person", "or", "entity", "that,", "among", "other", "things,", "knowingly", "presents,", "or", "causes", "to", "be", "presented,", "a", "false", "or", "fraudulent", "claim", "for", "payment", "by", "a", "federal", "healthcare", "program.", "<tag3>"], "wordsA": ["None", "of", "our", "employees", "are", "represented", "by", "a", "collective", "bargaining", "agreement."], "wordsB": ["The", "civil", "False", "Claims", "Act", "imposes", "liability", "on", "any", "person", "or", "entity", "that,", "among", "other", "things,", "knowingly", "presents,", "or", "causes", "to", "be", "presented,", "a", "false", "or", "fraudulent", "claim", "for", "payment", "by", "a", "federal", "healthcare", "program."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_16_item1_p113_s4", "idA": "3116_15_item1_p52_s2", "sentA": "Many of these components are available from only a single source and, in the case of many of our ANDAs and NDAs, only one supplier of raw materials has been identified.", "sentB": "Many of these state laws apply where a claim is submitted to any third-party payer and not merely a federal healthcare program.", "type": 1, "words": ["<tag1>", "Many", "of", "these", "components", "are", "available", "from", "only", "a", "single", "source", "and,", "in", "the", "case", "of", "many", "of", "our", "ANDAs", "and", "NDAs,", "only", "one", "supplier", "of", "raw", "materials", "has", "been", "identified.", "<tag2>", "Many", "of", "these", "state", "laws", "apply", "where", "a", "claim", "is", "submitted", "to", "any", "third-party", "payer", "and", "not", "merely", "a", "federal", "healthcare", "program.", "<tag3>"], "wordsA": ["Many", "of", "these", "components", "are", "available", "from", "only", "a", "single", "source", "and,", "in", "the", "case", "of", "many", "of", "our", "ANDAs", "and", "NDAs,", "only", "one", "supplier", "of", "raw", "materials", "has", "been", "identified."], "wordsB": ["Many", "of", "these", "state", "laws", "apply", "where", "a", "claim", "is", "submitted", "to", "any", "third-party", "payer", "and", "not", "merely", "a", "federal", "healthcare", "program."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_16_item1_p102_s4", "idA": "3116_15_item1_p52_s7", "sentA": "Any delays or failure of a contract manufacturing partner to supply finished goods timely or in adequate volume could impede our marketing of those products.", "sentB": "Other enforcement activities include refusal to approve product applications, withdrawal of previously approved applications or prohibition on marketing of certain unapproved products.", "type": 1, "words": ["<tag1>", "Any", "delays", "or", "failure", "of", "a", "contract", "manufacturing", "partner", "to", "supply", "finished", "goods", "timely", "or", "in", "adequate", "volume", "could", "impede", "our", "marketing", "of", "those", "products.", "<tag2>", "Other", "enforcement", "activities", "include", "refusal", "to", "approve", "product", "applications,", "withdrawal", "of", "previously", "approved", "applications", "or", "prohibition", "on", "marketing", "of", "certain", "unapproved", "products.", "<tag3>"], "wordsA": ["Any", "delays", "or", "failure", "of", "a", "contract", "manufacturing", "partner", "to", "supply", "finished", "goods", "timely", "or", "in", "adequate", "volume", "could", "impede", "our", "marketing", "of", "those", "products."], "wordsB": ["Other", "enforcement", "activities", "include", "refusal", "to", "approve", "product", "applications,", "withdrawal", "of", "previously", "approved", "applications", "or", "prohibition", "on", "marketing", "of", "certain", "unapproved", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_16_item1_p69_s1", "idA": "3116_15_item1_p54_s1", "sentA": "These three wholesale drug distributors account for a large portion of our gross sales, net revenues and accounts receivable in both of our segments.", "sentB": "Additional competition may emerge over time which could materially affect future revenues and profits.", "type": 1, "words": ["<tag1>", "These", "three", "wholesale", "drug", "distributors", "account", "for", "a", "large", "portion", "of", "our", "gross", "sales,", "net", "revenues", "and", "accounts", "receivable", "in", "both", "of", "our", "segments.", "<tag2>", "Additional", "competition", "may", "emerge", "over", "time", "which", "could", "materially", "affect", "future", "revenues", "and", "profits.", "<tag3>"], "wordsA": ["These", "three", "wholesale", "drug", "distributors", "account", "for", "a", "large", "portion", "of", "our", "gross", "sales,", "net", "revenues", "and", "accounts", "receivable", "in", "both", "of", "our", "segments."], "wordsB": ["Additional", "competition", "may", "emerge", "over", "time", "which", "could", "materially", "affect", "future", "revenues", "and", "profits."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_16_item1_p69_s2", "idA": "3116_15_item1_p54_s1", "sentA": "These three wholesale drug distributors account for a large portion of our gross sales, net revenues and accounts receivable in both of our segments.", "sentB": "In addition, future revenues and profits may be affected by events outside of our control including; disputes with partners, inability to timely source finished product from contract manufacturers or raw material suppliers and a failure to maintain or secure customer contracts at favorable terms.", "type": 1, "words": ["<tag1>", "These", "three", "wholesale", "drug", "distributors", "account", "for", "a", "large", "portion", "of", "our", "gross", "sales,", "net", "revenues", "and", "accounts", "receivable", "in", "both", "of", "our", "segments.", "<tag2>", "In", "addition,", "future", "revenues", "and", "profits", "may", "be", "affected", "by", "events", "outside", "of", "our", "control", "including;", "disputes", "with", "partners,", "inability", "to", "timely", "source", "finished", "product", "from", "contract", "manufacturers", "or", "raw", "material", "suppliers", "and", "a", "failure", "to", "maintain", "or", "secure", "customer", "contracts", "at", "favorable", "terms.", "<tag3>"], "wordsA": ["These", "three", "wholesale", "drug", "distributors", "account", "for", "a", "large", "portion", "of", "our", "gross", "sales,", "net", "revenues", "and", "accounts", "receivable", "in", "both", "of", "our", "segments."], "wordsB": ["In", "addition,", "future", "revenues", "and", "profits", "may", "be", "affected", "by", "events", "outside", "of", "our", "control", "including;", "disputes", "with", "partners,", "inability", "to", "timely", "source", "finished", "product", "from", "contract", "manufacturers", "or", "raw", "material", "suppliers", "and", "a", "failure", "to", "maintain", "or", "secure", "customer", "contracts", "at", "favorable", "terms."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_16_item1_p108_s1", "idA": "3116_15_item1_p58_s1", "sentA": "None of these distributors is an end user of our products.", "sentB": "These regulations govern access and reimbursement levels, including that all pharmaceutical companies pay rebates to individual states based on a percentage of sales arising from Medicaid-reimbursed products.", "type": 1, "words": ["<tag1>", "None", "of", "these", "distributors", "is", "an", "end", "user", "of", "our", "products.", "<tag2>", "These", "regulations", "govern", "access", "and", "reimbursement", "levels,", "including", "that", "all", "pharmaceutical", "companies", "pay", "rebates", "to", "individual", "states", "based", "on", "a", "percentage", "of", "sales", "arising", "from", "Medicaid-reimbursed", "products.", "<tag3>"], "wordsA": ["None", "of", "these", "distributors", "is", "an", "end", "user", "of", "our", "products."], "wordsB": ["These", "regulations", "govern", "access", "and", "reimbursement", "levels,", "including", "that", "all", "pharmaceutical", "companies", "pay", "rebates", "to", "individual", "states", "based", "on", "a", "percentage", "of", "sales", "arising", "from", "Medicaid-reimbursed", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_16_item1_p111_s1", "idA": "3116_15_item1_p58_s1", "sentA": "None of these distributors is an end user of our products.", "sentB": "Violations of these anti-kickback laws can lead to civil and/or criminal penalties, including fines, imprisonment and exclusion from participation in government healthcare programs.", "type": 1, "words": ["<tag1>", "None", "of", "these", "distributors", "is", "an", "end", "user", "of", "our", "products.", "<tag2>", "Violations", "of", "these", "anti-kickback", "laws", "can", "lead", "to", "civil", "and/or", "criminal", "penalties,", "including", "fines,", "imprisonment", "and", "exclusion", "from", "participation", "in", "government", "healthcare", "programs.", "<tag3>"], "wordsA": ["None", "of", "these", "distributors", "is", "an", "end", "user", "of", "our", "products."], "wordsB": ["Violations", "of", "these", "anti-kickback", "laws", "can", "lead", "to", "civil", "and/or", "criminal", "penalties,", "including", "fines,", "imprisonment", "and", "exclusion", "from", "participation", "in", "government", "healthcare", "programs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_16_item1_p120_s1", "idA": "3116_15_item1_p58_s1", "sentA": "None of these distributors is an end user of our products.", "sentB": "Violation of these laws and regulations, which frequently change, can lead to substantial fines and penalties.", "type": 1, "words": ["<tag1>", "None", "of", "these", "distributors", "is", "an", "end", "user", "of", "our", "products.", "<tag2>", "Violation", "of", "these", "laws", "and", "regulations,", "which", "frequently", "change,", "can", "lead", "to", "substantial", "fines", "and", "penalties.", "<tag3>"], "wordsA": ["None", "of", "these", "distributors", "is", "an", "end", "user", "of", "our", "products."], "wordsB": ["Violation", "of", "these", "laws", "and", "regulations,", "which", "frequently", "change,", "can", "lead", "to", "substantial", "fines", "and", "penalties."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_16_item1_p58_s2", "idA": "3116_15_item1_p58_s1", "sentA": "None of these distributors is an end user of our products.", "sentB": "Following our NDA approval, competitors marketing unapproved products discontinued distribution of their products.", "type": 1, "words": ["<tag1>", "None", "of", "these", "distributors", "is", "an", "end", "user", "of", "our", "products.", "<tag2>", "Following", "our", "NDA", "approval,", "competitors", "marketing", "unapproved", "products", "discontinued", "distribution", "of", "their", "products.", "<tag3>"], "wordsA": ["None", "of", "these", "distributors", "is", "an", "end", "user", "of", "our", "products."], "wordsB": ["Following", "our", "NDA", "approval,", "competitors", "marketing", "unapproved", "products", "discontinued", "distribution", "of", "their", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_16_item1_p109_s1", "idA": "3116_15_item1_p58_s3", "sentA": "However, the loss of one or more of these distributors, together with a delay or inability to secure an alternative distribution source for end users, could have a material negative impact on our revenue, business, financial condition and results of operations.", "sentB": "We cannot predict the nature of such potential future measures or the impact on our profitability.", "type": 1, "words": ["<tag1>", "However,", "the", "loss", "of", "one", "or", "more", "of", "these", "distributors,", "together", "with", "a", "delay", "or", "inability", "to", "secure", "an", "alternative", "distribution", "source", "for", "end", "users,", "could", "have", "a", "material", "negative", "impact", "on", "our", "revenue,", "business,", "financial", "condition", "and", "results", "of", "operations.", "<tag2>", "We", "cannot", "predict", "the", "nature", "of", "such", "potential", "future", "measures", "or", "the", "impact", "on", "our", "profitability.", "<tag3>"], "wordsA": ["However,", "the", "loss", "of", "one", "or", "more", "of", "these", "distributors,", "together", "with", "a", "delay", "or", "inability", "to", "secure", "an", "alternative", "distribution", "source", "for", "end", "users,", "could", "have", "a", "material", "negative", "impact", "on", "our", "revenue,", "business,", "financial", "condition", "and", "results", "of", "operations."], "wordsB": ["We", "cannot", "predict", "the", "nature", "of", "such", "potential", "future", "measures", "or", "the", "impact", "on", "our", "profitability."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_16_item1_p19_s1", "idA": "3116_15_item1_p5_s1", "sentA": "Branded marketed products include, among others, Akten , a topical ocular anesthetic gel, AzaSite , an antibiotic used to treat bacterial conjunctivitis, Cosopt , Cosopt PF, Betimol and Zioptan , which are used in the treatment of glaucoma, Nembutal , which is a sedative, and Xopenex Inhalation Solution, which is used in the treatment or prevention of bronchospasm.", "sentB": "Our flagship OTC brand is TheraTears Therapy for Your Eyes , which is a family of therapeutic eye care products including dry eye therapy lubricating eye drops, eyelid and eyelash cleansing foam and eye nutrition supplements.", "type": 1, "words": ["<tag1>", "Branded", "marketed", "products", "include,", "among", "others,", "Akten", ",", "a", "topical", "ocular", "anesthetic", "gel,", "AzaSite", ",", "an", "antibiotic", "used", "to", "treat", "bacterial", "conjunctivitis,", "Cosopt", ",", "Cosopt", "PF,", "Betimol", "and", "Zioptan", ",", "which", "are", "used", "in", "the", "treatment", "of", "glaucoma,", "Nembutal", ",", "which", "is", "a", "sedative,", "and", "Xopenex", "Inhalation", "Solution,", "which", "is", "used", "in", "the", "treatment", "or", "prevention", "of", "bronchospasm.", "<tag2>", "Our", "flagship", "OTC", "brand", "is", "TheraTears", "Therapy", "for", "Your", "Eyes", ",", "which", "is", "a", "family", "of", "therapeutic", "eye", "care", "products", "including", "dry", "eye", "therapy", "lubricating", "eye", "drops,", "eyelid", "and", "eyelash", "cleansing", "foam", "and", "eye", "nutrition", "supplements.", "<tag3>"], "wordsA": ["Branded", "marketed", "products", "include,", "among", "others,", "Akten", ",", "a", "topical", "ocular", "anesthetic", "gel,", "AzaSite", ",", "an", "antibiotic", "used", "to", "treat", "bacterial", "conjunctivitis,", "Cosopt", ",", "Cosopt", "PF,", "Betimol", "and", "Zioptan", ",", "which", "are", "used", "in", "the", "treatment", "of", "glaucoma,", "Nembutal", ",", "which", "is", "a", "sedative,", "and", "Xopenex", "Inhalation", "Solution,", "which", "is", "used", "in", "the", "treatment", "or", "prevention", "of", "bronchospasm."], "wordsB": ["Our", "flagship", "OTC", "brand", "is", "TheraTears", "Therapy", "for", "Your", "Eyes", ",", "which", "is", "a", "family", "of", "therapeutic", "eye", "care", "products", "including", "dry", "eye", "therapy", "lubricating", "eye", "drops,", "eyelid", "and", "eyelash", "cleansing", "foam", "and", "eye", "nutrition", "supplements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_16_item1_p115_s2", "idA": "3116_15_item1_p61_s0", "sentA": "Pharmaceutical manufacturers and distributors are subject to extensive regulation by government agencies, including the FDA, the Drug Enforcement Administration ( DEA ), the FTC and other federal, state and local agencies.", "sentB": "The rule sets forth a reporting process that permits physicians, teaching hospitals, and physician owners and investors to dispute information reported by applicable manufacturers and GPOs.", "type": 1, "words": ["<tag1>", "Pharmaceutical", "manufacturers", "and", "distributors", "are", "subject", "to", "extensive", "regulation", "by", "government", "agencies,", "including", "the", "FDA,", "the", "Drug", "Enforcement", "Administration", "(", "DEA", "),", "the", "FTC", "and", "other", "federal,", "state", "and", "local", "agencies.", "<tag2>", "The", "rule", "sets", "forth", "a", "reporting", "process", "that", "permits", "physicians,", "teaching", "hospitals,", "and", "physician", "owners", "and", "investors", "to", "dispute", "information", "reported", "by", "applicable", "manufacturers", "and", "GPOs.", "<tag3>"], "wordsA": ["Pharmaceutical", "manufacturers", "and", "distributors", "are", "subject", "to", "extensive", "regulation", "by", "government", "agencies,", "including", "the", "FDA,", "the", "Drug", "Enforcement", "Administration", "(", "DEA", "),", "the", "FTC", "and", "other", "federal,", "state", "and", "local", "agencies."], "wordsB": ["The", "rule", "sets", "forth", "a", "reporting", "process", "that", "permits", "physicians,", "teaching", "hospitals,", "and", "physician", "owners", "and", "investors", "to", "dispute", "information", "reported", "by", "applicable", "manufacturers", "and", "GPOs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_16_item1_p102_s3", "idA": "3116_15_item1_p61_s3", "sentA": "The FDA also has the authority to revoke approval of drug products.", "sentB": "This authority includes, but is not limited to, the authority to initiate judicial action to seize unapproved or non-complying products, to enjoin non-complying activities, to halt manufacturing operations that are not in compliance with cGMP, to recall products, to seek civil and monetary penalties and to criminally prosecute violators.", "type": 1, "words": ["<tag1>", "The", "FDA", "also", "has", "the", "authority", "to", "revoke", "approval", "of", "drug", "products.", "<tag2>", "This", "authority", "includes,", "but", "is", "not", "limited", "to,", "the", "authority", "to", "initiate", "judicial", "action", "to", "seize", "unapproved", "or", "non-complying", "products,", "to", "enjoin", "non-complying", "activities,", "to", "halt", "manufacturing", "operations", "that", "are", "not", "in", "compliance", "with", "cGMP,", "to", "recall", "products,", "to", "seek", "civil", "and", "monetary", "penalties", "and", "to", "criminally", "prosecute", "violators.", "<tag3>"], "wordsA": ["The", "FDA", "also", "has", "the", "authority", "to", "revoke", "approval", "of", "drug", "products."], "wordsB": ["This", "authority", "includes,", "but", "is", "not", "limited", "to,", "the", "authority", "to", "initiate", "judicial", "action", "to", "seize", "unapproved", "or", "non-complying", "products,", "to", "enjoin", "non-complying", "activities,", "to", "halt", "manufacturing", "operations", "that", "are", "not", "in", "compliance", "with", "cGMP,", "to", "recall", "products,", "to", "seek", "civil", "and", "monetary", "penalties", "and", "to", "criminally", "prosecute", "violators."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_16_item1_p102_s2", "idA": "3116_15_item1_p62_s0", "sentA": "FDA approval is required before any application drug product can be manufactured and marketed.", "sentB": "Under the FDC Act, the federal government has extensive administrative and judicial enforcement authority over the activities of finished drug product manufacturers to ensure compliance with FDA regulations.", "type": 1, "words": ["<tag1>", "FDA", "approval", "is", "required", "before", "any", "application", "drug", "product", "can", "be", "manufactured", "and", "marketed.", "<tag2>", "Under", "the", "FDC", "Act,", "the", "federal", "government", "has", "extensive", "administrative", "and", "judicial", "enforcement", "authority", "over", "the", "activities", "of", "finished", "drug", "product", "manufacturers", "to", "ensure", "compliance", "with", "FDA", "regulations.", "<tag3>"], "wordsA": ["FDA", "approval", "is", "required", "before", "any", "application", "drug", "product", "can", "be", "manufactured", "and", "marketed."], "wordsB": ["Under", "the", "FDC", "Act,", "the", "federal", "government", "has", "extensive", "administrative", "and", "judicial", "enforcement", "authority", "over", "the", "activities", "of", "finished", "drug", "product", "manufacturers", "to", "ensure", "compliance", "with", "FDA", "regulations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_16_item1_p62_s0", "idA": "3116_15_item1_p62_s0", "sentA": "FDA approval is required before any application drug product can be manufactured and marketed.", "sentB": "We began marketing Hydralazine Hydrochloride Injection, USP, 20 mg/mL in 1 mL single-dose vials following FDA approval in 2009.", "type": 1, "words": ["<tag1>", "FDA", "approval", "is", "required", "before", "any", "application", "drug", "product", "can", "be", "manufactured", "and", "marketed.", "<tag2>", "We", "began", "marketing", "Hydralazine", "Hydrochloride", "Injection,", "USP,", "20", "mg/mL", "in", "1", "mL", "single-dose", "vials", "following", "FDA", "approval", "in", "2009.", "<tag3>"], "wordsA": ["FDA", "approval", "is", "required", "before", "any", "application", "drug", "product", "can", "be", "manufactured", "and", "marketed."], "wordsB": ["We", "began", "marketing", "Hydralazine", "Hydrochloride", "Injection,", "USP,", "20", "mg/mL", "in", "1", "mL", "single-dose", "vials", "following", "FDA", "approval", "in", "2009."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_16_item1_p115_s3", "idA": "3116_15_item1_p63_s0", "sentA": "The time required by the FDA to review and approve NDAs and ANDAs is variable and, to a large extent, beyond our control.", "sentB": "Under the regulations, information that is the subject of a dispute not resolved within the initial allotted 60-day review and dispute resolution period will be posted on CMS s public website in the manner in which it was submitted by the manufacturer or GPO, rather than in a manner that includes the version provided by the disputing physician, teaching hospital, or physician owner or investor.", "type": 1, "words": ["<tag1>", "The", "time", "required", "by", "the", "FDA", "to", "review", "and", "approve", "NDAs", "and", "ANDAs", "is", "variable", "and,", "to", "a", "large", "extent,", "beyond", "our", "control.", "<tag2>", "Under", "the", "regulations,", "information", "that", "is", "the", "subject", "of", "a", "dispute", "not", "resolved", "within", "the", "initial", "allotted", "60-day", "review", "and", "dispute", "resolution", "period", "will", "be", "posted", "on", "CMS", "s", "public", "website", "in", "the", "manner", "in", "which", "it", "was", "submitted", "by", "the", "manufacturer", "or", "GPO,", "rather", "than", "in", "a", "manner", "that", "includes", "the", "version", "provided", "by", "the", "disputing", "physician,", "teaching", "hospital,", "or", "physician", "owner", "or", "investor.", "<tag3>"], "wordsA": ["The", "time", "required", "by", "the", "FDA", "to", "review", "and", "approve", "NDAs", "and", "ANDAs", "is", "variable", "and,", "to", "a", "large", "extent,", "beyond", "our", "control."], "wordsB": ["Under", "the", "regulations,", "information", "that", "is", "the", "subject", "of", "a", "dispute", "not", "resolved", "within", "the", "initial", "allotted", "60-day", "review", "and", "dispute", "resolution", "period", "will", "be", "posted", "on", "CMS", "s", "public", "website", "in", "the", "manner", "in", "which", "it", "was", "submitted", "by", "the", "manufacturer", "or", "GPO,", "rather", "than", "in", "a", "manner", "that", "includes", "the", "version", "provided", "by", "the", "disputing", "physician,", "teaching", "hospital,", "or", "physician", "owner", "or", "investor."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_16_item1_p115_s1", "idA": "3116_15_item1_p64_s0", "sentA": "We are subject to periodic inspections by the FDA and the DEA.", "sentB": "Under the regulations, applicable drug, biological, device, and medical supply manufacturers are required to report to CMS payments or other transfers of value made to physicians and teaching hospitals, and the regulations also require the manufacturers and GPOs to report ownership and investment interests held by physicians or their immediate family members.", "type": 1, "words": ["<tag1>", "We", "are", "subject", "to", "periodic", "inspections", "by", "the", "FDA", "and", "the", "DEA.", "<tag2>", "Under", "the", "regulations,", "applicable", "drug,", "biological,", "device,", "and", "medical", "supply", "manufacturers", "are", "required", "to", "report", "to", "CMS", "payments", "or", "other", "transfers", "of", "value", "made", "to", "physicians", "and", "teaching", "hospitals,", "and", "the", "regulations", "also", "require", "the", "manufacturers", "and", "GPOs", "to", "report", "ownership", "and", "investment", "interests", "held", "by", "physicians", "or", "their", "immediate", "family", "members.", "<tag3>"], "wordsA": ["We", "are", "subject", "to", "periodic", "inspections", "by", "the", "FDA", "and", "the", "DEA."], "wordsB": ["Under", "the", "regulations,", "applicable", "drug,", "biological,", "device,", "and", "medical", "supply", "manufacturers", "are", "required", "to", "report", "to", "CMS", "payments", "or", "other", "transfers", "of", "value", "made", "to", "physicians", "and", "teaching", "hospitals,", "and", "the", "regulations", "also", "require", "the", "manufacturers", "and", "GPOs", "to", "report", "ownership", "and", "investment", "interests", "held", "by", "physicians", "or", "their", "immediate", "family", "members."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_16_item1_p58_s1", "idA": "3116_15_item1_p65_s1", "sentA": "Failure to comply with DEA regulations can result in fines or seizure of product.", "sentB": "We had previously been marketing this product as an unapproved product.", "type": 1, "words": ["<tag1>", "Failure", "to", "comply", "with", "DEA", "regulations", "can", "result", "in", "fines", "or", "seizure", "of", "product.", "<tag2>", "We", "had", "previously", "been", "marketing", "this", "product", "as", "an", "unapproved", "product.", "<tag3>"], "wordsA": ["Failure", "to", "comply", "with", "DEA", "regulations", "can", "result", "in", "fines", "or", "seizure", "of", "product."], "wordsB": ["We", "had", "previously", "been", "marketing", "this", "product", "as", "an", "unapproved", "product."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_16_item1_p120_s2", "idA": "3116_15_item1_p69_s1", "sentA": "The majority of our products do not experience significant seasonality.", "sentB": "Some of our operations require environmental permits and controls to prevent and limit pollution.", "type": 1, "words": ["<tag1>", "The", "majority", "of", "our", "products", "do", "not", "experience", "significant", "seasonality.", "<tag2>", "Some", "of", "our", "operations", "require", "environmental", "permits", "and", "controls", "to", "prevent", "and", "limit", "pollution.", "<tag3>"], "wordsA": ["The", "majority", "of", "our", "products", "do", "not", "experience", "significant", "seasonality."], "wordsB": ["Some", "of", "our", "operations", "require", "environmental", "permits", "and", "controls", "to", "prevent", "and", "limit", "pollution."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_16_item1_p58_s0", "idA": "3116_15_item1_p69_s1", "sentA": "The majority of our products do not experience significant seasonality.", "sentB": "We received approval of our NDA for Atropine Sulfate Ophthalmic Solution, USP, 1% in July 2014.", "type": 1, "words": ["<tag1>", "The", "majority", "of", "our", "products", "do", "not", "experience", "significant", "seasonality.", "<tag2>", "We", "received", "approval", "of", "our", "NDA", "for", "Atropine", "Sulfate", "Ophthalmic", "Solution,", "USP,", "1%", "in", "July", "2014.", "<tag3>"], "wordsA": ["The", "majority", "of", "our", "products", "do", "not", "experience", "significant", "seasonality."], "wordsB": ["We", "received", "approval", "of", "our", "NDA", "for", "Atropine", "Sulfate", "Ophthalmic", "Solution,", "USP,", "1%", "in", "July", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_16_item1_p61_s2", "idA": "3116_15_item1_p69_s1", "sentA": "The majority of our products do not experience significant seasonality.", "sentB": "In 2015, we filed a New Drug Application seeking approval of our Ephedrine Sulfate Injection.", "type": 1, "words": ["<tag1>", "The", "majority", "of", "our", "products", "do", "not", "experience", "significant", "seasonality.", "<tag2>", "In", "2015,", "we", "filed", "a", "New", "Drug", "Application", "seeking", "approval", "of", "our", "Ephedrine", "Sulfate", "Injection.", "<tag3>"], "wordsA": ["The", "majority", "of", "our", "products", "do", "not", "experience", "significant", "seasonality."], "wordsB": ["In", "2015,", "we", "filed", "a", "New", "Drug", "Application", "seeking", "approval", "of", "our", "Ephedrine", "Sulfate", "Injection."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_16_item1_p14_s3", "idA": "3116_15_item1_p6_s0", "sentA": "The Company s Consumer Health segment represented approximately 8.5% of the Company s net sales in the year ended December 31, 2014 which was generated through the sale of branded and private label consumer and animal health products.", "sentB": "Our OTC and animal health portfolios are largely complementary to our human prescription products, allowing us to leverage our manufacturing and development expertise.", "type": 1, "words": ["<tag1>", "The", "Company", "s", "Consumer", "Health", "segment", "represented", "approximately", "8.5%", "of", "the", "Company", "s", "net", "sales", "in", "the", "year", "ended", "December", "31,", "2014", "which", "was", "generated", "through", "the", "sale", "of", "branded", "and", "private", "label", "consumer", "and", "animal", "health", "products.", "<tag2>", "Our", "OTC", "and", "animal", "health", "portfolios", "are", "largely", "complementary", "to", "our", "human", "prescription", "products,", "allowing", "us", "to", "leverage", "our", "manufacturing", "and", "development", "expertise.", "<tag3>"], "wordsA": ["The", "Company", "s", "Consumer", "Health", "segment", "represented", "approximately", "8.5%", "of", "the", "Company", "s", "net", "sales", "in", "the", "year", "ended", "December", "31,", "2014", "which", "was", "generated", "through", "the", "sale", "of", "branded", "and", "private", "label", "consumer", "and", "animal", "health", "products."], "wordsB": ["Our", "OTC", "and", "animal", "health", "portfolios", "are", "largely", "complementary", "to", "our", "human", "prescription", "products,", "allowing", "us", "to", "leverage", "our", "manufacturing", "and", "development", "expertise."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_16_item1_p3_s0", "idA": "3116_15_item1_p6_s1", "sentA": "The segment principally consists of OTC products focused on ophthalmics including dry eye treatment under the TheraTears brand name as well as a portfolio of private label OTC ophthalmic products.", "sentB": "Our common shares are traded on The NASDAQ Global Select Market under the ticker symbol AKRX.", "type": 1, "words": ["<tag1>", "The", "segment", "principally", "consists", "of", "OTC", "products", "focused", "on", "ophthalmics", "including", "dry", "eye", "treatment", "under", "the", "TheraTears", "brand", "name", "as", "well", "as", "a", "portfolio", "of", "private", "label", "OTC", "ophthalmic", "products.", "<tag2>", "Our", "common", "shares", "are", "traded", "on", "The", "NASDAQ", "Global", "Select", "Market", "under", "the", "ticker", "symbol", "AKRX.", "<tag3>"], "wordsA": ["The", "segment", "principally", "consists", "of", "OTC", "products", "focused", "on", "ophthalmics", "including", "dry", "eye", "treatment", "under", "the", "TheraTears", "brand", "name", "as", "well", "as", "a", "portfolio", "of", "private", "label", "OTC", "ophthalmic", "products."], "wordsB": ["Our", "common", "shares", "are", "traded", "on", "The", "NASDAQ", "Global", "Select", "Market", "under", "the", "ticker", "symbol", "AKRX."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_16_item1_p109_s0", "idA": "3116_15_item1_p70_s0", "sentA": "We maintain distribution contracts with the U.S. Federal Government ( Government ), including Veteran s Administration among others.", "sentB": "U.S. Federal and state governments may continue to enact legislation and other measures aimed at containing or reducing payment levels for prescription pharmaceuticals paid for in whole or in part with government funds.", "type": 1, "words": ["<tag1>", "We", "maintain", "distribution", "contracts", "with", "the", "U.S.", "Federal", "Government", "(", "Government", "),", "including", "Veteran", "s", "Administration", "among", "others.", "<tag2>", "U.S.", "Federal", "and", "state", "governments", "may", "continue", "to", "enact", "legislation", "and", "other", "measures", "aimed", "at", "containing", "or", "reducing", "payment", "levels", "for", "prescription", "pharmaceuticals", "paid", "for", "in", "whole", "or", "in", "part", "with", "government", "funds.", "<tag3>"], "wordsA": ["We", "maintain", "distribution", "contracts", "with", "the", "U.S.", "Federal", "Government", "(", "Government", "),", "including", "Veteran", "s", "Administration", "among", "others."], "wordsB": ["U.S.", "Federal", "and", "state", "governments", "may", "continue", "to", "enact", "legislation", "and", "other", "measures", "aimed", "at", "containing", "or", "reducing", "payment", "levels", "for", "prescription", "pharmaceuticals", "paid", "for", "in", "whole", "or", "in", "part", "with", "government", "funds."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_16_item1_p111_s0", "idA": "3116_15_item1_p70_s0", "sentA": "We maintain distribution contracts with the U.S. Federal Government ( Government ), including Veteran s Administration among others.", "sentB": "In the U.S. there are various federal and state anti-kickback laws that prohibit payment or receipt of kickbacks, bribes or other remuneration intended to induce the purchase or recommendation of healthcare products and services or reward past purchases or recommendations.", "type": 1, "words": ["<tag1>", "We", "maintain", "distribution", "contracts", "with", "the", "U.S.", "Federal", "Government", "(", "Government", "),", "including", "Veteran", "s", "Administration", "among", "others.", "<tag2>", "In", "the", "U.S.", "there", "are", "various", "federal", "and", "state", "anti-kickback", "laws", "that", "prohibit", "payment", "or", "receipt", "of", "kickbacks,", "bribes", "or", "other", "remuneration", "intended", "to", "induce", "the", "purchase", "or", "recommendation", "of", "healthcare", "products", "and", "services", "or", "reward", "past", "purchases", "or", "recommendations.", "<tag3>"], "wordsA": ["We", "maintain", "distribution", "contracts", "with", "the", "U.S.", "Federal", "Government", "(", "Government", "),", "including", "Veteran", "s", "Administration", "among", "others."], "wordsB": ["In", "the", "U.S.", "there", "are", "various", "federal", "and", "state", "anti-kickback", "laws", "that", "prohibit", "payment", "or", "receipt", "of", "kickbacks,", "bribes", "or", "other", "remuneration", "intended", "to", "induce", "the", "purchase", "or", "recommendation", "of", "healthcare", "products", "and", "services", "or", "reward", "past", "purchases", "or", "recommendations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_16_item1_p16_s1", "idA": "3116_15_item1_p70_s0", "sentA": "We maintain distribution contracts with the U.S. Federal Government ( Government ), including Veteran s Administration among others.", "sentB": "We added substantial talent to our management team in 2015 including a new Chief Financial Officer, a new head of commercial operations and a new head of pharmaceutical operations, among others.", "type": 1, "words": ["<tag1>", "We", "maintain", "distribution", "contracts", "with", "the", "U.S.", "Federal", "Government", "(", "Government", "),", "including", "Veteran", "s", "Administration", "among", "others.", "<tag2>", "We", "added", "substantial", "talent", "to", "our", "management", "team", "in", "2015", "including", "a", "new", "Chief", "Financial", "Officer,", "a", "new", "head", "of", "commercial", "operations", "and", "a", "new", "head", "of", "pharmaceutical", "operations,", "among", "others.", "<tag3>"], "wordsA": ["We", "maintain", "distribution", "contracts", "with", "the", "U.S.", "Federal", "Government", "(", "Government", "),", "including", "Veteran", "s", "Administration", "among", "others."], "wordsB": ["We", "added", "substantial", "talent", "to", "our", "management", "team", "in", "2015", "including", "a", "new", "Chief", "Financial", "Officer,", "a", "new", "head", "of", "commercial", "operations", "and", "a", "new", "head", "of", "pharmaceutical", "operations,", "among", "others."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_16_item1_p113_s3", "idA": "3116_15_item1_p72_s1", "sentA": "Our filings are available to the public at the website maintained by the SEC, http://www.sec.gov .", "sentB": "In addition, various states have enacted false claim laws analogous to the False Claims Act.", "type": 1, "words": ["<tag1>", "Our", "filings", "are", "available", "to", "the", "public", "at", "the", "website", "maintained", "by", "the", "SEC,", "http://www.sec.gov", ".", "<tag2>", "In", "addition,", "various", "states", "have", "enacted", "false", "claim", "laws", "analogous", "to", "the", "False", "Claims", "Act.", "<tag3>"], "wordsA": ["Our", "filings", "are", "available", "to", "the", "public", "at", "the", "website", "maintained", "by", "the", "SEC,", "http://www.sec.gov", "."], "wordsB": ["In", "addition,", "various", "states", "have", "enacted", "false", "claim", "laws", "analogous", "to", "the", "False", "Claims", "Act."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_16_item1_p8_s0", "idA": "3116_15_item1_p72_s3", "sentA": "The information contained on our web site is not a part of this document.", "sentB": "In order to successfully execute our strategy, we must continue to capitalize on our core strengths:", "type": 1, "words": ["<tag1>", "The", "information", "contained", "on", "our", "web", "site", "is", "not", "a", "part", "of", "this", "document.", "<tag2>", "In", "order", "to", "successfully", "execute", "our", "strategy,", "we", "must", "continue", "to", "capitalize", "on", "our", "core", "strengths:", "<tag3>"], "wordsA": ["The", "information", "contained", "on", "our", "web", "site", "is", "not", "a", "part", "of", "this", "document."], "wordsB": ["In", "order", "to", "successfully", "execute", "our", "strategy,", "we", "must", "continue", "to", "capitalize", "on", "our", "core", "strengths:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_16_item1_p18_s1", "idA": "3116_15_item1_p8_s0", "sentA": "We rely on our sales and marketing teams to help us maintain and, where possible, increase our market share in our predominantly non-proprietary product offering.", "sentB": "While we continue to primarily focus on generic products, our branded portfolio allows us to leverage our sales and manufacturing infrastructure and deepen our relationships with customers.", "type": 1, "words": ["<tag1>", "We", "rely", "on", "our", "sales", "and", "marketing", "teams", "to", "help", "us", "maintain", "and,", "where", "possible,", "increase", "our", "market", "share", "in", "our", "predominantly", "non-proprietary", "product", "offering.", "<tag2>", "While", "we", "continue", "to", "primarily", "focus", "on", "generic", "products,", "our", "branded", "portfolio", "allows", "us", "to", "leverage", "our", "sales", "and", "manufacturing", "infrastructure", "and", "deepen", "our", "relationships", "with", "customers.", "<tag3>"], "wordsA": ["We", "rely", "on", "our", "sales", "and", "marketing", "teams", "to", "help", "us", "maintain", "and,", "where", "possible,", "increase", "our", "market", "share", "in", "our", "predominantly", "non-proprietary", "product", "offering."], "wordsB": ["While", "we", "continue", "to", "primarily", "focus", "on", "generic", "products,", "our", "branded", "portfolio", "allows", "us", "to", "leverage", "our", "sales", "and", "manufacturing", "infrastructure", "and", "deepen", "our", "relationships", "with", "customers."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_16_item1_p72_s1", "idA": "3116_15_item1_p8_s1", "sentA": "Our sales organization consists of multiple teams, including: (1) regional outside sales teams focused on prescription pharmaceutical product sales; (2) an inside sales team focused on customers in smaller markets; (3) a national accounts sales team focused on wholesale, retail pharmacy chain and group purchasing organization ( GPO ) markets; and (4) a branded drug sales team focused on those branded prescription products.", "sentB": "Our sales organization is structured as follows:", "type": 1, "words": ["<tag1>", "Our", "sales", "organization", "consists", "of", "multiple", "teams,", "including:", "(1)", "regional", "outside", "sales", "teams", "focused", "on", "prescription", "pharmaceutical", "product", "sales;", "(2)", "an", "inside", "sales", "team", "focused", "on", "customers", "in", "smaller", "markets;", "(3)", "a", "national", "accounts", "sales", "team", "focused", "on", "wholesale,", "retail", "pharmacy", "chain", "and", "group", "purchasing", "organization", "(", "GPO", ")", "markets;", "and", "(4)", "a", "branded", "drug", "sales", "team", "focused", "on", "those", "branded", "prescription", "products.", "<tag2>", "Our", "sales", "organization", "is", "structured", "as", "follows:", "<tag3>"], "wordsA": ["Our", "sales", "organization", "consists", "of", "multiple", "teams,", "including:", "(1)", "regional", "outside", "sales", "teams", "focused", "on", "prescription", "pharmaceutical", "product", "sales;", "(2)", "an", "inside", "sales", "team", "focused", "on", "customers", "in", "smaller", "markets;", "(3)", "a", "national", "accounts", "sales", "team", "focused", "on", "wholesale,", "retail", "pharmacy", "chain", "and", "group", "purchasing", "organization", "(", "GPO", ")", "markets;", "and", "(4)", "a", "branded", "drug", "sales", "team", "focused", "on", "those", "branded", "prescription", "products."], "wordsB": ["Our", "sales", "organization", "is", "structured", "as", "follows:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_17_item1_p108_s0", "idA": "3116_16_item1_p78_s1", "sentA": "With the Company s relatively small OTC and animal health product portfolio many of our competitors have substantially greater financial and other resources, including greater sales volume, larger sales forces and greater manufacturing capacity.", "sentB": "All full-time Akorn employees are eligible to participate in the Company s 401(k) Plan.", "type": 1, "words": ["<tag1>", "With", "the", "Company", "s", "relatively", "small", "OTC", "and", "animal", "health", "product", "portfolio", "many", "of", "our", "competitors", "have", "substantially", "greater", "financial", "and", "other", "resources,", "including", "greater", "sales", "volume,", "larger", "sales", "forces", "and", "greater", "manufacturing", "capacity.", "<tag2>", "All", "full-time", "Akorn", "employees", "are", "eligible", "to", "participate", "in", "the", "Company", "s", "401(k)", "Plan.", "<tag3>"], "wordsA": ["With", "the", "Company", "s", "relatively", "small", "OTC", "and", "animal", "health", "product", "portfolio", "many", "of", "our", "competitors", "have", "substantially", "greater", "financial", "and", "other", "resources,", "including", "greater", "sales", "volume,", "larger", "sales", "forces", "and", "greater", "manufacturing", "capacity."], "wordsB": ["All", "full-time", "Akorn", "employees", "are", "eligible", "to", "participate", "in", "the", "Company", "s", "401(k)", "Plan."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_17_item1_p108_s2", "idA": "3116_16_item1_p78_s2", "sentA": "Within this market, we compete primarily on product offering, as well as price and service.", "sentB": "Company matching contributions vest 50% after two years of credited service and 100% after three years of credited service.", "type": 1, "words": ["<tag1>", "Within", "this", "market,", "we", "compete", "primarily", "on", "product", "offering,", "as", "well", "as", "price", "and", "service.", "<tag2>", "Company", "matching", "contributions", "vest", "50%", "after", "two", "years", "of", "credited", "service", "and", "100%", "after", "three", "years", "of", "credited", "service.", "<tag3>"], "wordsA": ["Within", "this", "market,", "we", "compete", "primarily", "on", "product", "offering,", "as", "well", "as", "price", "and", "service."], "wordsB": ["Company", "matching", "contributions", "vest", "50%", "after", "two", "years", "of", "credited", "service", "and", "100%", "after", "three", "years", "of", "credited", "service."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_18_item1_p7_s0", "idA": "3116_17_item1_p100_s0", "sentA": "We are also subject to the provisions of the federal civil False Claims Act and, in particular, actions brought pursuant to the False Claims Act s whistleblower or qui tam provisions.", "sentB": "Completion of the Merger is subject to customary closing conditions, including (1) there being no judgment or law enjoining or otherwise prohibiting the consummation of the Merger and (2) the expiration of the waiting period applicable to the Merger under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended.", "type": 1, "words": ["<tag1>", "We", "are", "also", "subject", "to", "the", "provisions", "of", "the", "federal", "civil", "False", "Claims", "Act", "and,", "in", "particular,", "actions", "brought", "pursuant", "to", "the", "False", "Claims", "Act", "s", "whistleblower", "or", "qui", "tam", "provisions.", "<tag2>", "Completion", "of", "the", "Merger", "is", "subject", "to", "customary", "closing", "conditions,", "including", "(1)", "there", "being", "no", "judgment", "or", "law", "enjoining", "or", "otherwise", "prohibiting", "the", "consummation", "of", "the", "Merger", "and", "(2)", "the", "expiration", "of", "the", "waiting", "period", "applicable", "to", "the", "Merger", "under", "the", "Hart-Scott-Rodino", "Antitrust", "Improvements", "Act", "of", "1976,", "as", "amended.", "<tag3>"], "wordsA": ["We", "are", "also", "subject", "to", "the", "provisions", "of", "the", "federal", "civil", "False", "Claims", "Act", "and,", "in", "particular,", "actions", "brought", "pursuant", "to", "the", "False", "Claims", "Act", "s", "whistleblower", "or", "qui", "tam", "provisions."], "wordsB": ["Completion", "of", "the", "Merger", "is", "subject", "to", "customary", "closing", "conditions,", "including", "(1)", "there", "being", "no", "judgment", "or", "law", "enjoining", "or", "otherwise", "prohibiting", "the", "consummation", "of", "the", "Merger", "and", "(2)", "the", "expiration", "of", "the", "waiting", "period", "applicable", "to", "the", "Merger", "under", "the", "Hart-Scott-Rodino", "Antitrust", "Improvements", "Act", "of", "1976,", "as", "amended."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_18_item1_p7_s1", "idA": "3116_17_item1_p112_s1", "sentA": "Information on the operation of the Public Reference Room may be obtained by calling the SEC at 1-800-SEC-0330.", "sentB": "The obligation of each of the Company and Parent to consummate the Merger is also conditioned on the other party s representations and warranties being true and correct (subject to certain materiality exceptions) and the other party having performed in all material respects its obligations under the Merger Agreement.", "type": 1, "words": ["<tag1>", "Information", "on", "the", "operation", "of", "the", "Public", "Reference", "Room", "may", "be", "obtained", "by", "calling", "the", "SEC", "at", "1-800-SEC-0330.", "<tag2>", "The", "obligation", "of", "each", "of", "the", "Company", "and", "Parent", "to", "consummate", "the", "Merger", "is", "also", "conditioned", "on", "the", "other", "party", "s", "representations", "and", "warranties", "being", "true", "and", "correct", "(subject", "to", "certain", "materiality", "exceptions)", "and", "the", "other", "party", "having", "performed", "in", "all", "material", "respects", "its", "obligations", "under", "the", "Merger", "Agreement.", "<tag3>"], "wordsA": ["Information", "on", "the", "operation", "of", "the", "Public", "Reference", "Room", "may", "be", "obtained", "by", "calling", "the", "SEC", "at", "1-800-SEC-0330."], "wordsB": ["The", "obligation", "of", "each", "of", "the", "Company", "and", "Parent", "to", "consummate", "the", "Merger", "is", "also", "conditioned", "on", "the", "other", "party", "s", "representations", "and", "warranties", "being", "true", "and", "correct", "(subject", "to", "certain", "materiality", "exceptions)", "and", "the", "other", "party", "having", "performed", "in", "all", "material", "respects", "its", "obligations", "under", "the", "Merger", "Agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_18_item1_p8_s0", "idA": "3116_17_item1_p14_s2", "sentA": "We are actively pursuing FDA approval of this facility.", "sentB": "The Merger Agreement contains representations and warranties and covenants of the parties customary for a transaction of this nature.", "type": 1, "words": ["<tag1>", "We", "are", "actively", "pursuing", "FDA", "approval", "of", "this", "facility.", "<tag2>", "The", "Merger", "Agreement", "contains", "representations", "and", "warranties", "and", "covenants", "of", "the", "parties", "customary", "for", "a", "transaction", "of", "this", "nature.", "<tag3>"], "wordsA": ["We", "are", "actively", "pursuing", "FDA", "approval", "of", "this", "facility."], "wordsB": ["The", "Merger", "Agreement", "contains", "representations", "and", "warranties", "and", "covenants", "of", "the", "parties", "customary", "for", "a", "transaction", "of", "this", "nature."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_18_item1_p5_s0", "idA": "3116_17_item1_p1_s0", "sentA": "Akorn is a Louisiana corporation founded in 1971 in Abita Springs, Louisiana.", "sentB": "On April 24, 2017, the Company entered into an Agreement and Plan of Merger (the Merger Agreement ) with Fresenius Kabi AG, a German stock corporation ( Parent ), Quercus Acquisition, Inc., a Louisiana corporation and wholly-owned subsidiary of Parent ( Merger Sub ) and, solely for purposes of Article VIII thereof, Fresenius SE Co. KGaA, a German partnership limited by shares.", "type": 1, "words": ["<tag1>", "Akorn", "is", "a", "Louisiana", "corporation", "founded", "in", "1971", "in", "Abita", "Springs,", "Louisiana.", "<tag2>", "On", "April", "24,", "2017,", "the", "Company", "entered", "into", "an", "Agreement", "and", "Plan", "of", "Merger", "(the", "Merger", "Agreement", ")", "with", "Fresenius", "Kabi", "AG,", "a", "German", "stock", "corporation", "(", "Parent", "),", "Quercus", "Acquisition,", "Inc.,", "a", "Louisiana", "corporation", "and", "wholly-owned", "subsidiary", "of", "Parent", "(", "Merger", "Sub", ")", "and,", "solely", "for", "purposes", "of", "Article", "VIII", "thereof,", "Fresenius", "SE", "Co.", "KGaA,", "a", "German", "partnership", "limited", "by", "shares.", "<tag3>"], "wordsA": ["Akorn", "is", "a", "Louisiana", "corporation", "founded", "in", "1971", "in", "Abita", "Springs,", "Louisiana."], "wordsB": ["On", "April", "24,", "2017,", "the", "Company", "entered", "into", "an", "Agreement", "and", "Plan", "of", "Merger", "(the", "Merger", "Agreement", ")", "with", "Fresenius", "Kabi", "AG,", "a", "German", "stock", "corporation", "(", "Parent", "),", "Quercus", "Acquisition,", "Inc.,", "a", "Louisiana", "corporation", "and", "wholly-owned", "subsidiary", "of", "Parent", "(", "Merger", "Sub", ")", "and,", "solely", "for", "purposes", "of", "Article", "VIII", "thereof,", "Fresenius", "SE", "Co.", "KGaA,", "a", "German", "partnership", "limited", "by", "shares."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_18_item1_p6_s0", "idA": "3116_17_item1_p30_s0", "sentA": "To expand our ophthalmic manufacturing capacity, our Luxembourg subsidiary, Akorn International S. r.l., closed a share purchase agreement on January 2, 2015 with Fareva SA to acquire all of the issued and outstanding shares of capital stock of Excelvision AG, a Swiss company ( Excelvision AG ).", "sentB": "Subject to the terms and conditions set forth in the Merger Agreement, at the effective time of the Merger (the Effective Time ), each of the Company s issued and outstanding shares of common stock, no par value per share (the Shares ) (other than Shares owned by the Company or by Parent, Merger Sub or any direct or indirect wholly-owned subsidiary of the Company or of Parent (other than Merger Sub) immediately prior to the Effective Time), will be converted into the right to receive $34.00 in cash per Share (the Merger Consideration ), without interest.", "type": 1, "words": ["<tag1>", "To", "expand", "our", "ophthalmic", "manufacturing", "capacity,", "our", "Luxembourg", "subsidiary,", "Akorn", "International", "S.", "r.l.,", "closed", "a", "share", "purchase", "agreement", "on", "January", "2,", "2015", "with", "Fareva", "SA", "to", "acquire", "all", "of", "the", "issued", "and", "outstanding", "shares", "of", "capital", "stock", "of", "Excelvision", "AG,", "a", "Swiss", "company", "(", "Excelvision", "AG", ").", "<tag2>", "Subject", "to", "the", "terms", "and", "conditions", "set", "forth", "in", "the", "Merger", "Agreement,", "at", "the", "effective", "time", "of", "the", "Merger", "(the", "Effective", "Time", "),", "each", "of", "the", "Company", "s", "issued", "and", "outstanding", "shares", "of", "common", "stock,", "no", "par", "value", "per", "share", "(the", "Shares", ")", "(other", "than", "Shares", "owned", "by", "the", "Company", "or", "by", "Parent,", "Merger", "Sub", "or", "any", "direct", "or", "indirect", "wholly-owned", "subsidiary", "of", "the", "Company", "or", "of", "Parent", "(other", "than", "Merger", "Sub)", "immediately", "prior", "to", "the", "Effective", "Time),", "will", "be", "converted", "into", "the", "right", "to", "receive", "$34.00", "in", "cash", "per", "Share", "(the", "Merger", "Consideration", "),", "without", "interest.", "<tag3>"], "wordsA": ["To", "expand", "our", "ophthalmic", "manufacturing", "capacity,", "our", "Luxembourg", "subsidiary,", "Akorn", "International", "S.", "r.l.,", "closed", "a", "share", "purchase", "agreement", "on", "January", "2,", "2015", "with", "Fareva", "SA", "to", "acquire", "all", "of", "the", "issued", "and", "outstanding", "shares", "of", "capital", "stock", "of", "Excelvision", "AG,", "a", "Swiss", "company", "(", "Excelvision", "AG", ")."], "wordsB": ["Subject", "to", "the", "terms", "and", "conditions", "set", "forth", "in", "the", "Merger", "Agreement,", "at", "the", "effective", "time", "of", "the", "Merger", "(the", "Effective", "Time", "),", "each", "of", "the", "Company", "s", "issued", "and", "outstanding", "shares", "of", "common", "stock,", "no", "par", "value", "per", "share", "(the", "Shares", ")", "(other", "than", "Shares", "owned", "by", "the", "Company", "or", "by", "Parent,", "Merger", "Sub", "or", "any", "direct", "or", "indirect", "wholly-owned", "subsidiary", "of", "the", "Company", "or", "of", "Parent", "(other", "than", "Merger", "Sub)", "immediately", "prior", "to", "the", "Effective", "Time),", "will", "be", "converted", "into", "the", "right", "to", "receive", "$34.00", "in", "cash", "per", "Share", "(the", "Merger", "Consideration", "),", "without", "interest."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_18_item1_p66_s0", "idA": "3116_17_item1_p38_s2", "sentA": "See Item 1A - Risk Factors for a description of risks that accompany our business development.", "sentB": "TheraTears Dry Eye Therapy Lubricant Eye Drops.", "type": 1, "words": ["<tag1>", "See", "Item", "1A", "-", "Risk", "Factors", "for", "a", "description", "of", "risks", "that", "accompany", "our", "business", "development.", "<tag2>", "TheraTears", "Dry", "Eye", "Therapy", "Lubricant", "Eye", "Drops.", "<tag3>"], "wordsA": ["See", "Item", "1A", "-", "Risk", "Factors", "for", "a", "description", "of", "risks", "that", "accompany", "our", "business", "development."], "wordsB": ["TheraTears", "Dry", "Eye", "Therapy", "Lubricant", "Eye", "Drops."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_18_item1_p66_s2", "idA": "3116_17_item1_p38_s2", "sentA": "See Item 1A - Risk Factors for a description of risks that accompany our business development.", "sentB": "TheraTears unique hypotonic and electrolyte balanced formula replicates healthy tears.", "type": 1, "words": ["<tag1>", "See", "Item", "1A", "-", "Risk", "Factors", "for", "a", "description", "of", "risks", "that", "accompany", "our", "business", "development.", "<tag2>", "TheraTears", "unique", "hypotonic", "and", "electrolyte", "balanced", "formula", "replicates", "healthy", "tears.", "<tag3>"], "wordsA": ["See", "Item", "1A", "-", "Risk", "Factors", "for", "a", "description", "of", "risks", "that", "accompany", "our", "business", "development."], "wordsB": ["TheraTears", "unique", "hypotonic", "and", "electrolyte", "balanced", "formula", "replicates", "healthy", "tears."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_18_item1_p8_s1", "idA": "3116_17_item1_p45_s1", "sentA": "Upon entering into the product acquisition agreement, we entered into supply agreements with Merck and a third party to ensure continued supply of the three products.", "sentB": "Among other things, Parent has agreed to promptly take all actions necessary to obtain antitrust approval of the Merger, including (i) entering into consent decrees or undertakings with a regulatory authority, (ii) divesting or holding separate any assets or businesses of Parent or the Company, (iii) terminating existing contractual relationships or entering into new contractual relationships, (iv) effecting any other change or restructuring of Parent or the Company and (v) defending through litigation any claim asserted by a regulatory authority that would prevent the closing of the Merger.", "type": 1, "words": ["<tag1>", "Upon", "entering", "into", "the", "product", "acquisition", "agreement,", "we", "entered", "into", "supply", "agreements", "with", "Merck", "and", "a", "third", "party", "to", "ensure", "continued", "supply", "of", "the", "three", "products.", "<tag2>", "Among", "other", "things,", "Parent", "has", "agreed", "to", "promptly", "take", "all", "actions", "necessary", "to", "obtain", "antitrust", "approval", "of", "the", "Merger,", "including", "(i)", "entering", "into", "consent", "decrees", "or", "undertakings", "with", "a", "regulatory", "authority,", "(ii)", "divesting", "or", "holding", "separate", "any", "assets", "or", "businesses", "of", "Parent", "or", "the", "Company,", "(iii)", "terminating", "existing", "contractual", "relationships", "or", "entering", "into", "new", "contractual", "relationships,", "(iv)", "effecting", "any", "other", "change", "or", "restructuring", "of", "Parent", "or", "the", "Company", "and", "(v)", "defending", "through", "litigation", "any", "claim", "asserted", "by", "a", "regulatory", "authority", "that", "would", "prevent", "the", "closing", "of", "the", "Merger.", "<tag3>"], "wordsA": ["Upon", "entering", "into", "the", "product", "acquisition", "agreement,", "we", "entered", "into", "supply", "agreements", "with", "Merck", "and", "a", "third", "party", "to", "ensure", "continued", "supply", "of", "the", "three", "products."], "wordsB": ["Among", "other", "things,", "Parent", "has", "agreed", "to", "promptly", "take", "all", "actions", "necessary", "to", "obtain", "antitrust", "approval", "of", "the", "Merger,", "including", "(i)", "entering", "into", "consent", "decrees", "or", "undertakings", "with", "a", "regulatory", "authority,", "(ii)", "divesting", "or", "holding", "separate", "any", "assets", "or", "businesses", "of", "Parent", "or", "the", "Company,", "(iii)", "terminating", "existing", "contractual", "relationships", "or", "entering", "into", "new", "contractual", "relationships,", "(iv)", "effecting", "any", "other", "change", "or", "restructuring", "of", "Parent", "or", "the", "Company", "and", "(v)", "defending", "through", "litigation", "any", "claim", "asserted", "by", "a", "regulatory", "authority", "that", "would", "prevent", "the", "closing", "of", "the", "Merger."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_18_item1_p57_s0", "idA": "3116_17_item1_p60_s0", "sentA": "Most of the products discussed above have several generic equivalent competitors.", "sentB": "AK-FLUOR is indicated in diagnostic fluorescein angiography or angioscopy of the retina and iris vasculature.", "type": 1, "words": ["<tag1>", "Most", "of", "the", "products", "discussed", "above", "have", "several", "generic", "equivalent", "competitors.", "<tag2>", "AK-FLUOR", "is", "indicated", "in", "diagnostic", "fluorescein", "angiography", "or", "angioscopy", "of", "the", "retina", "and", "iris", "vasculature.", "<tag3>"], "wordsA": ["Most", "of", "the", "products", "discussed", "above", "have", "several", "generic", "equivalent", "competitors."], "wordsB": ["AK-FLUOR", "is", "indicated", "in", "diagnostic", "fluorescein", "angiography", "or", "angioscopy", "of", "the", "retina", "and", "iris", "vasculature."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_18_item1_p66_s1", "idA": "3116_17_item1_p60_s0", "sentA": "Most of the products discussed above have several generic equivalent competitors.", "sentB": "TheraTears is an over-the-counter eye drop that is used as a lubricant to relieve dryness of the eye.", "type": 1, "words": ["<tag1>", "Most", "of", "the", "products", "discussed", "above", "have", "several", "generic", "equivalent", "competitors.", "<tag2>", "TheraTears", "is", "an", "over-the-counter", "eye", "drop", "that", "is", "used", "as", "a", "lubricant", "to", "relieve", "dryness", "of", "the", "eye.", "<tag3>"], "wordsA": ["Most", "of", "the", "products", "discussed", "above", "have", "several", "generic", "equivalent", "competitors."], "wordsB": ["TheraTears", "is", "an", "over-the-counter", "eye", "drop", "that", "is", "used", "as", "a", "lubricant", "to", "relieve", "dryness", "of", "the", "eye."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_18_item1_p56_s0", "idA": "3116_17_item1_p68_s1", "sentA": "Additionally, potential generic entrants with equivalent products referencing our branded products present an additional competitive threat.", "sentB": "We market our branded fluorescein injection as AK-FLUOR 10% (100 mg/mL) and 25% (250 mg/mL).", "type": 1, "words": ["<tag1>", "Additionally,", "potential", "generic", "entrants", "with", "equivalent", "products", "referencing", "our", "branded", "products", "present", "an", "additional", "competitive", "threat.", "<tag2>", "We", "market", "our", "branded", "fluorescein", "injection", "as", "AK-FLUOR", "10%", "(100", "mg/mL)", "and", "25%", "(250", "mg/mL).", "<tag3>"], "wordsA": ["Additionally,", "potential", "generic", "entrants", "with", "equivalent", "products", "referencing", "our", "branded", "products", "present", "an", "additional", "competitive", "threat."], "wordsB": ["We", "market", "our", "branded", "fluorescein", "injection", "as", "AK-FLUOR", "10%", "(100", "mg/mL)", "and", "25%", "(250", "mg/mL)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_18_item1_p5_s2", "idA": "3116_17_item1_p90_s4", "sentA": "Other enforcement activities include refusal to approve product applications, withdrawal of previously approved applications or prohibition on marketing of certain unapproved products.", "sentB": "On July 19, 2017, the Company's shareholders voted to approve the Merger Agreement.", "type": 1, "words": ["<tag1>", "Other", "enforcement", "activities", "include", "refusal", "to", "approve", "product", "applications,", "withdrawal", "of", "previously", "approved", "applications", "or", "prohibition", "on", "marketing", "of", "certain", "unapproved", "products.", "<tag2>", "On", "July", "19,", "2017,", "the", "Company's", "shareholders", "voted", "to", "approve", "the", "Merger", "Agreement.", "<tag3>"], "wordsA": ["Other", "enforcement", "activities", "include", "refusal", "to", "approve", "product", "applications,", "withdrawal", "of", "previously", "approved", "applications", "or", "prohibition", "on", "marketing", "of", "certain", "unapproved", "products."], "wordsB": ["On", "July", "19,", "2017,", "the", "Company's", "shareholders", "voted", "to", "approve", "the", "Merger", "Agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_18_item1_p5_s1", "idA": "3116_17_item1_p91_s3", "sentA": "An ANDA does not, for the most part, require clinical studies since safety and efficacy have already been demonstrated by the product originator.", "sentB": "The Merger Agreement, which has been adopted by the Board of Directors of the Company, provides for the merger of Merger Sub with and into the Company (the Merger ), with the Company surviving the Merger as a wholly-owned subsidiary of Parent.", "type": 1, "words": ["<tag1>", "An", "ANDA", "does", "not,", "for", "the", "most", "part,", "require", "clinical", "studies", "since", "safety", "and", "efficacy", "have", "already", "been", "demonstrated", "by", "the", "product", "originator.", "<tag2>", "The", "Merger", "Agreement,", "which", "has", "been", "adopted", "by", "the", "Board", "of", "Directors", "of", "the", "Company,", "provides", "for", "the", "merger", "of", "Merger", "Sub", "with", "and", "into", "the", "Company", "(the", "Merger", "),", "with", "the", "Company", "surviving", "the", "Merger", "as", "a", "wholly-owned", "subsidiary", "of", "Parent.", "<tag3>"], "wordsA": ["An", "ANDA", "does", "not,", "for", "the", "most", "part,", "require", "clinical", "studies", "since", "safety", "and", "efficacy", "have", "already", "been", "demonstrated", "by", "the", "product", "originator."], "wordsB": ["The", "Merger", "Agreement,", "which", "has", "been", "adopted", "by", "the", "Board", "of", "Directors", "of", "the", "Company,", "provides", "for", "the", "merger", "of", "Merger", "Sub", "with", "and", "into", "the", "Company", "(the", "Merger", "),", "with", "the", "Company", "surviving", "the", "Merger", "as", "a", "wholly-owned", "subsidiary", "of", "Parent."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "3116_18_item1_p28_s0", "idA": "3116_17_item1_p9_s1", "sentA": "Our R D efforts are primarily focused on the development of multisource generic products that are in dosage forms other than oral solid dose.", "sentB": "In addition to our internal development work, we strategically partner with drug development and contract manufacturing companies ( CMOs ) throughout the world for the development of drug products that we believe will complement our existing product offerings, but for which we may lack the expertise to develop, or the capability, capacity or cost-efficiencies to manufacture.", "type": 1, "words": ["<tag1>", "Our", "R", "D", "efforts", "are", "primarily", "focused", "on", "the", "development", "of", "multisource", "generic", "products", "that", "are", "in", "dosage", "forms", "other", "than", "oral", "solid", "dose.", "<tag2>", "In", "addition", "to", "our", "internal", "development", "work,", "we", "strategically", "partner", "with", "drug", "development", "and", "contract", "manufacturing", "companies", "(", "CMOs", ")", "throughout", "the", "world", "for", "the", "development", "of", "drug", "products", "that", "we", "believe", "will", "complement", "our", "existing", "product", "offerings,", "but", "for", "which", "we", "may", "lack", "the", "expertise", "to", "develop,", "or", "the", "capability,", "capacity", "or", "cost-efficiencies", "to", "manufacture.", "<tag3>"], "wordsA": ["Our", "R", "D", "efforts", "are", "primarily", "focused", "on", "the", "development", "of", "multisource", "generic", "products", "that", "are", "in", "dosage", "forms", "other", "than", "oral", "solid", "dose."], "wordsB": ["In", "addition", "to", "our", "internal", "development", "work,", "we", "strategically", "partner", "with", "drug", "development", "and", "contract", "manufacturing", "companies", "(", "CMOs", ")", "throughout", "the", "world", "for", "the", "development", "of", "drug", "products", "that", "we", "believe", "will", "complement", "our", "existing", "product", "offerings,", "but", "for", "which", "we", "may", "lack", "the", "expertise", "to", "develop,", "or", "the", "capability,", "capacity", "or", "cost-efficiencies", "to", "manufacture."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
